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ABSTRACT 
 
In the earlier studies of this research group, short estrous cycles were noted in a small 
number of heifers and cows when estrus and ovulation were induced with agonistic 
analogues of prostaglandin F2α (PG) and gonadotropin-releasing hormone (GnRH) 
treatments administered to cyclic animals 24 h apart. This premature ovulation induced a 
shortened luteal phase in some animals, and the premature luteal regression was confirmed 
to be caused by premature, endogenous release of PGF2α, resembling the release during 
spontaneous luteal regression. Follicular size before and at ovulation, and the subsequent 
luteal size, were both unaffected by the treatment. Induction of ovulation 24 h after PG 
also significantly weakened estrous signs. Possible causes for such induced short estrous 
cycles in dairy cattle were further elucidated in the four experiments described in this 
thesis. 
 
In Experiment I, estrus and ovulation were induced in heifers with PG and GnRH given 24 
h apart during early (Day 7 after ovulation) or late (Day 14 after ovulation) diestrus, and 
the occurrence of induced short estrous cycles was compared between the groups. The 
preovulatory release of LH during the hour before and 6 h after GnRH administration and 
the basal release of LH on Days 1, 3 and 5 after ovulation were compared between the 
above-mentioned groups and an unmanipulated control group. Short estrous cycles 
occurred similarly when PG and GnRH were given either during early or late diestrus. The 
preovulatory and basal post-ovulatory release of LH on Days 1, 3 and 5 after ovulation 
were similar for early and late diestrus, and also for short and normal length estrous cycles. 
Lower basal LH concentration after ovulation coincided with higher progesterone 
concentration. The size of the preovulatory follicle during the three days before ovulation 
was significantly different for early and late diestrus, and also for short and normal length 
cycles three days and one day before ovulation (P < 0.05). 
 
In Experiment II, the effect of gonadorelin doses of 0.1 mg or 0.5 mg given 24 h after PG 
during early diestrus on the occurrence of short estrous cycles, and on the preovulatory 
release of LH during 6 h following gonadorelin administration was investigated in cyclic 
dairy heifers. The dose of gonadorelin did not have a significant effect on the occurrence 
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of induced short estrous cycles. The preovulatory release of LH was similar irrespective of 
the gonadorelin dose, as was the size of the preovulatory follicle. 
 
In Experiment III, the effect of the time interval between PG and GnRH (0 vs. 24 h) given 
during early diestrus (Day 7 after ovulation) on the occurrence of short estrous cycles was 
investigated in cyclic dairy heifers and cows. Short estrous cycles occurred more 
frequently after simultaneous administration of PG and GnRH in heifers, in comparison 
with administration 24 h apart (P < 0.01). The number of excluded cases due to 
unresponsiveness to GnRH appeared to be higher when the time interval between 
treatments was decreased. The size of the preovulatory follicle was similar in both groups. 
 
In Experiment IV, the expression of endometrial receptors oxytocin, estrogen-α and 
progesterone and enzymes 20α-hydroxysteroid-dehydrogenase and cyclo-oxygenase-II, on 
Days 2 and 5 after ovulation was analyzed with real-time quantitative reverse 
transcriptase-polymerase chain reaction and immunohistochemistry. PG and GnRH were 
given 24 h apart to dairy cows during early diestrus (Day 8 after ovulation). Also 
peripheral blood estradiol-17β concentration was compared between induced short and 
normal length estrous cycles. No significant difference on Days 2 and 5 after ovulation in 
any of these receptors or enzymes were recorded between induced short and normal length 
cycles. The size of the preovulatory follicle was similar for short and normal length cycles, 
and was not related to the concentration of estradiol-17β. 
 
According to the literature, events during follicular development and ovulation as well as 
during formation, support and regression of the CL could all lead to a shortened inter-
estrous interval. The work reported in this thesis focused mainly on the events during the 
periovulatory period and also on the beginning of the luteal phase (until Day 5 post-
ovulation). In summary, the occurrence of induced short estrous cycles was significantly 
increased with simultaneous administration of PG and GnRH, but was neither related to 
the size of the preovulatory follicle nor to the GnRH-induced preovulatory release of LH. 
Also the basal postovulatory release of LH on Days 1, 3 and 5 after ovulation was similar 
for induced short and normal length estrous cycles. The size of the preovulatory follicle 
was significantly larger when PG and GnRH were given 24 h apart during early diestrus in 
comparison with late diestrus, but the occurrence of short estrous cycles was similar for the 
groups. The size of the preovulatory follicle in cows did not correlate with the 
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preovulatory secretion of estradiol-17β. The endometrial expressions of receptors ER, OR 
and PR and enzymes 20α-HSD and COX-II were similar for short and normal length 
estrous cycles. The exact cause of induced short estrous cycles remains to be established. 
The results described should be taken into account in estrus synchronization protocols 
utilizing sequential treatments with PG and GnRH in order to avoid reduced fertility due to 
induced short estrous cycles.  
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1. INTRODUCTION 
 
Dairy cows are the most important production animals in Finland (Vuorisalo 2014). At the 
end of 2013 there were approximately 8800 dairy farms in Finland (Vuorisalo 2014) and 
the number of dairy cows at the beginning of May 2014 was approximately 285 250 (Luke 
2015). In 2013, these cows produced 2260 million liters of milk (Vuorisalo 2014). The 
most common dairy breeds in Finland were Ayrshire (59%) and Holstein (39.5%). There 
are also some dairy cows of Finnish Landrace breeds (1.2%) and the Jersey breed (n=237) 
(Faba 2015b). The average milk production of Finnish Ayrshire, Holstein, Landrace and 
Jersey breeds in 2013 was 8644, 9518, 6117 and 7872 liters, respectively. 
 
In 2013, data from almost all dairy farms (89.2%) were gathered in a national dairy disease 
register (Faba 2015a). The most common reason for treatments of those dairy herds was 
various fertility disorders (18.4% of all animals). The second and third most common 
health problems were mastitis and other udder-related illness (14.5%) and milk fever 
(3.4%). Thus, approximately every fifth dairy cow on those farms was treated for fertility 
problems. The number of cows treated for fertility disorders increases with increasing milk 
production: when the level of milk production is high (exceeds 10500 kg per cow per 
year), the percentage of treated animals is also high (28.8%), and when the level of milk 
production is low (less than 7500 kg per cow per year), the percentage of treated animals is 
lower (13.1%). In 2013, at an annual average milk production level of 8845 kg per cow, 
the percentage of cows treated for fertility disorders was 16.2%. The average calving 
interval on those farms was 420 days in 2013. 
 
Fertility in modern, highly-productive dairy cows in comparison with heifers has 
decreased worldwide (Wiltbank et al. 2011). This is due to increased milk production and 
hormonal imbalances, mainly progesterone, estradiol, luteinizing hormone (LH), follicle 
stimulating hormone (FSH) and gonadotropin releasing hormone (GnRH) around estrus. 
This results in decreased estradiol-17β secretion around estrus, ovulation of large and aged 
follicles, and/or increased frequency of anovulation or double ovulation (Wiltbank et al. 
2011). In practice, decreased fertility warrants use of hormonal estrus synchronization 
protocols to control follicular waves and luteal regression to achieve acceptable pregnancy 
rates. The goal is to shorten the time of follicular dominance and to increase the length of 
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proestrus, without unwanted side effects such as short estrous cycles (Wiltbank et al. 
2011). Several protocols for estrus and ovulation synchronization have been developed for 
dairy and beef cattle. These have used agonistic analogues of prostaglandin F2 (PG) and 
GnRH in different combinations and doses, after different time intervals and/or with other 
hormones (estradiol, progesterone, eCG or FSH) or with calf removal, and were recently 
reviewed by Wiltbank and Pursley (2014). The duration of the luteal phase is most 
commonly reduced with PG causing luteal regression and increased with progesterone 
extending follicular dominance, or with GnRH or estradiol which cause changes in 
follicular wave dynamics (Macmillan et al. 2003). The length of the follicular phase is 
most often reduced via induction of ovulation with GnRH or estradiol (Macmillan et al. 
2003). The goal of these sequential hormonal treatments is to allow timed artificial 
insemination after synchronization of ovulation, i.e. to regulate the CL, ovarian follicles 
and the whole periovulatory hormonal milieu correctly (Wiltbank et al. 2011, Wiltbank 
and Pursley 2014). 
 
Aberrations in these hormonal estrus synchronization regimes can lead to unwantedly 
reduced fertility, as reported by Peters and Pursley (2003). They investigated the optimal 
time interval (0, 12, 24 and 36 h) between PG and GnRH, and short estrous cycles 
occurred more frequently as the time interval between treatments decreased. However, 
after numerous studies, according to Wiltbank and Pursley (2014), further research is 
needed to make these estrus synchronization protocols more effective, simple, practical 
and synchronious. The early diestrus, i.e. first five to eight days after synchronization 
protocols remains a grey zone, and therefore research should also be focused on that period 
(Skarzynski et al. 2013). More specifically, reasons behind the decreased progesterone 
secretion occurring after synchronization treatments as well as the causes of refractoriness 
of the newly developed CL to exogenous PG should be analysed further (Skarzynski et al. 
2013). In a recent study, Sahu et al. (2014) investigated the GnRH - PGF2α - GnRH (GPG) 
estrus synchronization protocol in dairy heifers with or without exogenous progesterone, 
and concluded that the positive effects of external progesterone administration are not 
mediated via changes in follicular dynamics. Further studies were warranted, and short 
estrous cycles occurring after synchronization of estrus were mentioned as a point of focus 
(Sahu et al. 2014). 
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Physiological short estrous cycles are common in postpartum cows and in pre-pubertal 
heifers, and lead to low pregnancy rates if animals are bred to such cycles (Garverick and 
Smith 1986, Lishman and Inskeep 1991, Hunter 1991, Garverick et al. 1992). Short estrous 
cycles can be induced in cyclic cattle when PG and GnRH are given in sufficiently close 
succession (Stevens et al. 1993). Similarly to postpartum short cycles, induced short 
estrous cycles clearly are of low fertility, despite a progestagen phase preceding them. In a 
study by Pursley et al. (1994), the pregnancy rate after simultaneous PG and GnRH 
administration was only 9%, compared with 55% when GnRH was given 48 h after PG 
and 46 % when the time interval between treatments was 24 h. 
 
Earlier possible reasons behind short cycles were speculated to be “1) lack of sufficient 
luteotropin, 2) failure of the luteal tissue to recognize a luteotropin, and 3) presence of a 
luteolytic agent” (Odde et al. 1980). According to Garverick and Smith (1986), short 
cycles could be due to disturbances during both follicular and luteal phases. Events during 
follicular development and ovulation as well as during formation, support and regression 
of the CL could all lead to a shortened inter-estrous interval (Garverick and Smith 1986). 
Copelin et al. (1987) thought that mechanisms might be inadequate luteotropic stimuli, a 
premature release of or increased sensitivity to a luteolysin, or both, increased sensitivity 
of the CL to PGF2α, and an increased or premature release of PGF2α. Currently, the most 
accepted of these seems to be the presence of a prematurely released luteolytic agent, 
PGF2α. 
 
In sheep, Brown et al. (2014) investigated endocrine and ovarian receptor changes during 
male-induced, physiological short estrous cycles in anestrous females. Before ovulation, a 
moderate loss of steroid acute regulatory protein (STAR) gene expression on thecal cells 
was detected, and at or following ovulation, significant changes in expression of genes 
involved in progesterone synthesis (STAR, CYP11A1, HAD3B1) and vascular 
development (VEGFA, VEGFR2) took place. No changes in expression of these genes on 
granulosal cells were detected. No changes in PGFM or in receptors for PGF2α were 
recorded for short and normal length cycles. On Day 3 after the male-effect, the variation 
in the expression of the genes investigated was large, but two subpopulations could be 
differentiated; they were assumed to represent normal (high expression) and short (low 
expression) length cycles. The inadequate degree of STAR expression on thecal cells was 
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assumed to cause short cycles via follicle dysfunction, and the authors questioned the role 
of PGF2α in causing physiological short cycles in ewes (Brown et al. 2014).  
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2. REVIEW OF THE LITERATURE 
 
2.1. Events during follicular and luteal phase of the bovine estrous cycle 
 
Cattle are polyestrous, puberty occurring at the age of 6 to 12 months when animals weigh 
about 200 to 250 kg (reviewed by Forde et al. 2011). The length of the normal estrous 
cycle is 21 ± 3 days, consisting of two phases separated by ovulation: follicular (proestrus 
and estrus, 4 to 6 days) and luteal (metestrus and diestrus, 14 to 18 days) (Forde et al. 
2011). Follicular development starts as a response to FSH secreted from the hypophysis 
after hypothalamic release of GnRH (reviewed by Driancourt 2001). This causes 5 to 10 
small (1 to 3 mm), gonadotropin-sensitive follicles to start growing. As these follicles 
reach about 4 mm in diameter, they become gonadotropin-dependent. This is termed 
follicular recruitment or wave emergence, and lasts for about two days. As the cohort of 
follicles matures, they become able to synthesize estradiol-17β from androgens (aromatase 
activity), insulin-like growth factor (IGF), activin, follistatin and inhibin, and their size 
dominance changes to functional dominance. During follicular growth, follistatin binds 
activin, causing the activin/inhibin-balance to change in favour of inhibin, and FSH 
decreases the production of IGF binding proteins (IGFBP) leading to increased 
concentration of unbound IGF. Aromatase activity and estradiol-17β production are 
increased by IGF and FSH, and increased concentrations of inhibin and estradiol-17β 
decrease FSH concentration, thus ending the period of follicular recruitment. Normally 
only one follicle (8 mm) is the first to be able to synthesize LH receptors on its granulosa 
cells (Driancourt 2001). This first follicle continues to develop with the aid of LH in the 
changing hormonal environment and becomes the dominant follicle. The subordinate 
follicles enter atresia due to decreased FSH. The level of androgens produced in thecal 
cells increase due to LH, inhibin and IGF. During the dominance phase, the dominant 
follicle continues to grow, and both nuclear and cytoplasmic maturation are needed for an 
ovum to become fertilized (Driancourt 2001). 
 
Each follicular wave lasts about 7 to 10 days, and if the general hormonal milieu allows, 
the dominant follicle ovulates as a response to changes in LH secretion pattern (reviewed 
by Diskin et al. 2002). If ovulation does not take place, the dominant follicle enters atresia, 
and a new follicular wave can grow (Diskin et al. 2002). Most commonly two or three 
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follicular waves occur during the estrous cycle: one ovulatory and one or two non-
ovulatory (Savio et al. 1988). According to Sirois and Fortune (1988), three follicular 
waves usually occur during an estrous cycle. In three-wave-cycles, follicular waves start 
approximately on Days 2, 9 and 16 (Sirois and Fortune 1988), and the dominant follicle is 
of maximum size on average on Days 6, 16 and 21 (Savio et al. 1988), and in two-waves-
cycles, on average, on Days 6 and 15 (Savio et al. 1988). The dominant follicle of the 
second follicular wave is significantly smaller than that of the first wave or the third wave 
during the same cycle (Sirois and Fortune 1988). The diameter of the preovulatory follicle 
becomes larger than the diameter of other follicles during the same cycle (Savio et al. 
1988). The maximum size of the dominant follicle in the first, second or third follicular 
wave in heifers, according to Sirois and Fortune (1988), ranged between 12 and 13 mm, 8 
and 11.5 mm or 12 and 14 mm, respectively. Savio et al. (1988) reported that the 
maximum size of the dominant follicle in heifers was approximately 15 mm in the first and 
the second wave, and approximately 19 mm in the third wave. 
 
As the LH peak induces the dominant follicle to ovulate, a dynamic transition from 
follicular to luteal phase starts (metestrus, 3 to 4 days) and the secretion of estradiol-17β 
from the ovulatory follicle ceases (reviewed by Diaz et al. 2002). The basement membrane 
breaks, small (~ 17 µm) and large (~ 38 µm) luteal cells develop from follicular thecal and 
granulosal cells of the follicle, respectively, and the CL thus formed begins to produce 
progesterone. Large luteal cells are independent of LH and secrete 80% of progesterone, 
but also have receptors for estradiol-17β and PGF2α. Small luteal cells have more LH 
receptors and fewer receptors for estradiol-17β and PGF2α than the large luteal cells. 
Synthesis of progesterone in these cells is mainly constitutive, continuous and autonomous 
without acute stimulatory control (Diaz et al. 2002). LH causes blood-derived circulating 
lipoproteins to be converted to progesterone via pregnenolone (Diaz et al. 2002). The 
important capacity of the corpus luteum to regress at the appropriate time makes the CL a 
transient endocrine gland. Around Day 7, the capacity for luteal regression is gained and 
luteal cells are able to produce and release more PGF2α in response to a small amount of 
uterine PGF2α (Diaz et al. 2002). This creates a positive, auto-amplifying feedback loop 
leading to both functional and structural regression of the CL. After an adequate amount of 
PGF2α is reached, peripheral blood progesterone is decreased within 12 h (Diaz et al. 
2002). A schematic representation of reproductive hormones secreted from the 
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hypothalamus, anterior pituitary, ovaries and uterus, and their possible interactions is given 
in Figure 2.1.A. 
 
In summary, the 21 ± 3 day long estrous cycles in cows consists most usually of two to 
three follicular waves, each lasting approximately 7 to 10 days. The estrous cycle is 
divided into the follicular and luteal phases, separated by LH-induced ovulation. After 
ovulation, secretion of estradiol-17β ceases, the CL is formed and the secretion of 
progesterone begins. At luteal regression, PGF2α causes structural and functional 
regression of the CL. 
 
 
 
 
 
 
Figure 2.1.A. A schematic representation of reproductive hormones and their possible interactions - 
gonadotropin-releasing hormone (GnRH), follicle stimulating hormone (FSH), luteinizing hormone 
(LH), estradiol-17β, inhibin, progesterone and prostaglandin F2α (PG) - secreted from the 
hypothalamus, anterior pituitary, ovaries and uterus. 
  
•  Follicles: 
estradiol-17β, 
inhibin 
•  CL: progesterone 
•  PG 
•  FSH 
•  LH 
• GnRH 
Hypothalamus 
Anterior 
pituitary 
Ovaries Uterus 
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2.2. Physiological short estrous cycles and their incidences 
 
According to Odde et al. (1980), the most common length of physiological short estrous 
cycles is 8 days and the range is from 7 to 10 days. The incidence in their material of 
almost 3000 postpartum beef cows was 7% and 86% of short cycles were detected 
between the first and the second estrus postpartum. Hinshelwood et al. (1982) reported the 
incidence of short cycles (less than 17 days) in postpartum dairy cows to be 11%. The 
mean length of such short cycles was 11 days. Visual observation, rectal palpation and/or 
vasectomized bulls were used for heat detection in their study. According to Mackey et al. 
(2000), the length of postpartum short estrous cycles in suckling beef cows was 12.0 ± 1.5 
days, and was almost unchanged if suckling was restricted to once daily (11.3 ± 1.2 days). 
Similarly, Stevens et al. (1993) reported the length of short cycles to vary between 7 to 13 
days in diestrous dairy cows. In contrast, Schrick et al. (1993) reported a shorter luteal life 
span in postpartum beef cows exhibiting a short luteal phase, 6.9 ± 0.3 days. Standing 
estrus is less common during the follicular phase preceding these physiological short luteal 
phases in comparison with the follicular phase of the normal length cycles (Ramirez-
Godinez et al. 1982b), and exogenous progesterone treatment significantly increases the 
number of beef cows exhibiting estrous signs at first estrus postpartum (Mackey et al. 
2000).  Cows inseminated or mated during the follicular phase of these short cycles do not 
conceive (Odde et al. 1980, Breuel et al. 1993). 
 
Time from the ultrasonographical detection of a ≥ 5 mm follicle to ovulation in postpartum 
beef cows is significantly longer in normal cycles than in physiological short cycles 
(Schrick et al. 1993). Peaks of FSH and LH precede progesterone elevation during 
physiological short estrous cycles (Manns et al. 1983). The CL during these short luteal 
phases is morphologically normal, containing both large and small luteal cells (Manns et 
al. 1983). Fertilization, transportation from the oviduct to the uterus and early development 
of the embryo have been evaluated with the aid of embryo flushing (Ramirez-Godinez et 
al. 1982a, Breuel et al. 1993); both ovulation and fertilization are normal during the estrus 
preceding the short luteal phase (Ramirez-Godinez et al. 1982a, Breuel et al. 1993), and 
fertility at mating or insemination prior to the short luteal phase is not affected (Breuel et 
al. 1993, Schrick et al. 1993). The ova are normally transported from the oviduct to the 
uterus after fertilization, and also develop to the 4- or 8-cell stage similarly in untreated 
post-weaning beef cows exhibiting short cycles in comparison with norgestomet-treated 
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controls with normal length estrous cycles (Breuel et al. 1993). The rate of recovery, 
quality and developmental stage of embryos flushed from the uterus on Day 6 after estrus 
in postpartum beef cows does not differ between physiological short and normal length 
cycles (Schrick et al. 1993). Recovery rates of embryos in oviductal flushing (Day 3 after 
estrus) or uterine flushing (Day 6 after estrus) of beef cows are similar in post-weaning 
short estrous cycles and in norgestomet-treated controls (Breuel et al. 1993). In contrast, 
for normal, cyclic recipients Schrick et al. (1993) reported a tendency towards lower 
embryonic survival for donors exhibiting a short cycle than for donors inseminated in a 
normal cycle (23% vs. 47%, respectively, p = 0.08). The overall pregnancy rate of normal, 
cyclic recipients tended to be less for embryos from short cycle animals than for embryos 
from normal cycle animals (13% vs. 32%, respectively, p = 0.06), but statistical 
significance was not reached (Schrick et al. 1993). 
 
Most studies concerning physiological short estrous cycles and their prevention have been 
done in beef cows and with exogenous progestagen supplementation prior to post-weaning 
estrus. In post-weaning beef cows the incidence of 8 to 12 day long physiological short 
cycles was 83% (Ramirez-Godinez et al. 1981). This incidence was reduced to zero when 
animals were pre-treated for nine days with norgestomet implanted at weaning (Ramirez-
Godinez et al. 1981). If animals were implanted nine days before weaning, the incidence of 
short cycles was reduced to 30%, and also the conception rate increased from 0 to 33% 
(implant before weaning) or to 80% (implant at weaning). Troxel and Kesler (1984) used 
0.25 mg of GnRH 24 h after progestagen implant for eight days in suckling, postpartum 
beef cows. This protocol induced ovulation in all cows, in comparison to significantly 
reduced ovulation rate in those given only GnRH (83%) or no treatment (0%). Animals 
given only GnRH had significantly more 8 to 12 days cycles than those treated with 
progestin and GnRH (80% vs. 33%, respectively). In a similar study by Schrick et al. 
(1993), the incidence of postpartum short cycles in beef cows was reduced from 74% in 
untreated controls to 21% in norgestomet-treated animals (implant for nine days, weaning 
seven days later). Also Breuel et al. (1993) noted the positive effect of exogenous 
progesterone as the pregnancy rate increased from nil (postweaning, untreated beef cow 
exhibiting short estrous cycle) to 50% (exogenous norgestomet for nine days, weaning 
seven days later, normal length cycles). Similarly, Mackey et al. (2000) significantly 
reduced the frequency of physiological short estrous cycles in postpartum beef cows with 
exogenous progesterone. Sheffel et al. (1982) reported that beef cows pre-treated with 
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norgestomet had a normal length cycle (19.6 d) compared with a short cycle length (13.4 
d) in non-treated controls. Rutter et al. (1985) demonstrated a 53% incidence of short 
cycles when ovulation in beef cows was induced with 0.2 mg of GnRH 30 days 
postpartum. This incidence was effectively reduced with progesterone pre-treatment for 
four days prior to GnRH. Garverick and Smith (1986) reported similar resuts: the estrous 
cycle length was significantly shorter in untreated postpartum beef cows in comparison 
with norgestomet-treated ones. If daily peroral or injectable progestagen supplementation 
was started later (on Day 4 after mating or insemination), early luteal regression was not 
prevented (Breuel et al. 1993). 
 
In conclusion, a preceding progestagen phase is essential in reducing the incidence of 
physiological, postpartum short cycles, and significantly improves fertility. Usually 
physiological short estrous cycles are exhibited between the first and the second ovulation 
postpartum. The length of physiological short cycles is less than two weeks. Signs of 
estrus are less visible, but ovulation, fertilization and transport of the ovum to the uterus 
occur normally. If animals are inseminated or mated during the follicular phase preceding 
these short luteal phases, fertility is nil. 
 
2.3. Induced short estrous cycles and their incidences 
 
Short estrous cycles also result when cyclic cattle are treated with PG and GnRH in 
sufficiently close succession (Stevens et al. 1993) when a preceding progestagen phase 
does not inhibit the occurrence of the short cycles. Schmitt et al. (1996) gave PG and 8 μg 
of buserelin 24 h apart to cyclic cows and heifers, and the incidence of induced short 
estrous cycles was about 35%. Cruz et al. (1997) reported short estrous cycles in 23% of 
cyclic, suckling beef cows treated with PG and 0.1 mg of gonadorelin 30 h apart - the 
incidence of short estrous cycles was lowest as the time interval between PG and GnRH 
administration was the longest. In a study of Taponen et al. (1999), a short estrous cycle of 
9 to 10 days was recorded in 1/6 heifers and 1/3 cows that ovulated after PG and 0.1 mg of 
gonadorelin were given 24 h apart during early diestrus to cyclic animals. In subsequent 
similar studies of Taponen et al. (2002, 2003), the incidence was about 33% in cows 
(Taponen et al. 2002) and about 58% in heifers (Taponen et al. 2003). When the time 
interval between administration PG and 0.1 mg of gonadorelin is decreased from 2.2 to 1.2 
days, the number of induced short estrous cycles in cyclic beef cows is increased from 
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12.5% to 50% (p = 0.1; Bridges et al. 2010). Similarly, when the time interval decreased 
from 2.25 days to 1.25 days, the proportion of short cycles significantly increased from 
35% to 82% (Bridges et al. 2010). The effect of simultaneous treatment with PG and 0.1 
mg of gonadorelin on Day 8 or Day 10 after standing estrus was noted by Stevens et al. 
(1993): all five cows that had an induced ovulation in 48 h after GnRH was given 
exhibited a short cycle (7 to 13 days). The authors concluded that such a hormonal 
protocol did not improve estrous synchrony compared with giving PG alone because it did 
not allow normal follicular development. When PG and 10 g of buserelin were given to 
cyclic dairy cows either 40 h or 60 h apart, the percentages of animals without a functional 
CL on Day 7 after ovulation were 25% and 6%, respectively (Bollwein et al. 2010). In 
comparison, after spontaneous ovulation, 12% of animals had no functional CL on that 
day.  
 
In a recent study by Núñez-Olivera et al. (2014), postpartum, anestrous beef cows (n = 46) 
received an intravaginal progesterone-releasing device combined with 2 mg of estradiol 
benzoate. At removal of the device eight days later, they were given 0.5 mg of estradiol 
cypionate and 0.5 mg of cloprostenol, and half of the animals also 400 IU of eCG. 
Ovulation rate was significantly increased with eCG, but despite pre-treatment with 
progesterone, eight short estrous cycles occurred (8/22; 36%). These short cycles were 
assumed to be caused by inadequate luteotropic support via decreased secretion of LH due 
to low body condition score. The length of these short cycles was either seven days (three 
cases after eCG and one case without eCG) or twelve days (three cases without eCG and 
one case after eCG). However, the authors did not specify whether the short luteal phases 
were physiological or induced, or both. 
 
Similarly to physiological short estrous cycles, induced short luteal phases clearly decrease 
fertility if animals are bred to those cycles. The conception rate after simultaneous PG and 
GnRH administration was only 9% in comparison with 55% when GnRH was given 48 h 
after PG (Pursley et al. 1994). A significant reduction in pregnancy rates on Day 30 was 
also reported by Bridges et al. (2010): PG and 0.1 mg of gonadorelin given 1.25 days or 
2.25 days apart resulted in pregnancy rates of 2.6% and 50.0%, respectively (P < 0.01). In 
another study with heifers, the pregnancy rates were 26% and 46% when GnRH was 
administered 24 or 48 h after PG, respectively (Schmitt et al. 1996). In comparison, the 
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pregnancy rate after artificial insemination at behavioural estrus in the same study was 
48%. The reduced pregnancy rate was thought to be caused by short estrous cycles that 
were due to a GnRH-induced surge of LH prior to adequate development of the 
preovulatory follicle. When GnRH was given 24 or 48 h after PG, approximately 35% and 
16% of heifers exhibited a shortened inter-estrus interval ( 16 days), respectively 
(Schmitt et al. 1996). Changing GnRH to hCG did not prevent the reduction in conception 
rate (Schmitt et al. 1996). 
 
In conclusion, induced short estrous cycles are due to PG and GnRH given to cyclic 
animals in sufficiently close succession. The occurrence of these short luteal phases is 
increased when the time interval between PG and GnRH treatments is decreased. Induced 
short cycles are not prevented by a preceding progestagen phase. Fertility is also reduced 
when the time interval between PG and GnRH administration is decreased. 
 
2.4. Hypothalamus-hypophysis-gonadal-axis 
 
2.4.1. Gonadotropin releasing hormone 
 
The hypothalamus synthesizes and releases gonadotropin releasing hormone, a 
decapeptide hormone GnRH. Its primary target organ is the pituitary, where, with high 
affinity, it binds to its receptors (GnRH-R) on the gonadotropic cell membranes, and 
releases LH and FSH. The amount of GnRH-R determines the effect of GnRH, and is 
regulated by GnRH itself, progesterone, estrogen, inhibin and activin (reviewed by Rispoli 
and Nett 2005). Normal pulsatory secretion of GnRH is necessary to maintain GnRH-R on 
the cell membranes. Continuous secretion of GnRH suppresses GnRH-R. During estrus 
(i.e. phase of low progesterone) the secretory pattern of GnRH changes allowing the up-
regulation of GnRH-R. Thus, progesterone seems to be a very important regulator for 
GnRH-R. When progesterone level is high, the level of GnRH-R is down-regulated, and 
during periods of low progesterone, it is up-regulated, i.e. progesterone has a negative 
effect on the level of GnRH-R (Rispoli and Nett 2005). Estrogen and activin in turn 
increase, and inhibin decreases the level of GnRH-R up-regulation. The highest level of 
GnRH-R is reached just before ovulation, and is essential for the preovulatory release of 
LH (Rispoli and Nett 2005). 
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2.4.2. LH release in response to exogenous gonadotropin releasing hormone 
 
Analysis and description of the LH secretion from the pituitary can be done using several 
parameters. The magnitude of secretion is described by the amplitude of the LH peak 
and/or with total secretion evaluated as the area under the LH curve (AUC). Other 
parameters used are the time interval between GnRH administration and LH peak and the 
duration of the LH surge. According to Mikél Jensen et al. (1983) and Chenault et al. 
(1990), AUC is the best tool to estimate the GnRH-induced LH release quantitatively. 
After PG and 0.1 mg of gonadorelin were given 48 h apart to dairy cows, the peak release 
of LH was reached 1.5 h later (Bas et al. 2014). After PG and 0.1 mg of gonadorelin 
administration 72 h apart, the duration of LH secretion in heifers was 4.0 to 6.8 h (Lucy 
and Stevenson 1986). Around luteolysis, a natural-like LH peak in heifers may be induced 
with as little as 5 µg of gonadorelin (Ginther and Beg 2012).  
 
The individual variation in LH responses is considerable (Yamada et al. 2002). In many 
studies, and especially with higher GnRH doses, no dose effect of GnRH on LH secretion 
has been demonstrated (Kaltenbach et al. 1974, Fonseca et al. 1980, Wettemann et al. 
1982, Yamada et al. 2002). Zolman et al. (1984) found a significant effect of gonadorelin 
dose on LH concentrations, but only with the lowest doses, when 0.005, 0.04 or 0.32 mg of 
gonadorelin was given during late diestrus and proestrus to dairy heifers. Schams et al. 
(1974) observed a linear dose dependency of the LH release from 0.0625 mg up to 1.5 mg 
of gonadorelin. The differences in responses between doses of 0.25 mg and 0.5 mg 
appeared non-significant. Some studies in cyclic or anestrous beef or dairy cows 
demonstrated that by using such GnRH levels as used in practice, or even lower, a positive 
linear effect on LH secretion was achieved (Echternkamp et al. 1978, Mikél Jensen et al. 
1983, Chenault et al. 1990, Mee et al. 1993). Chenault et al. (1990) used various doses of 
GnRH products at their labelled dosages in nine replicates for each treatment: saline; 
0.025, 0.05, 0.1 or 0.2 mg of fertirelin acetate; 0.1, 0.25 or 0.5 mg of gonadorelin; and 0.01 
or 0.02 mg of buserelin, all given to dairy heifers during diestrus. A classical dose 
response, measured in terms of both peak concentration and AUC, was observed in LH 
concentration following injection of fertirelin acetate. However, the increase was not 
significantly different between doses of 0.1 mg and 0.2 mg. Gonadorelin and buserelin 
treatments gave similar dose responses, but results were not tested statistically. Mikél 
Jensen et al. (1983) studied the dose response for gonadorelin in dairy heifers treated at 
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five dose levels (0, 0.01, 0.05, 0.1, and 0.25 mg) and on five treatment days during 
proestrus and early diestrus. The LH response increased with increasing doses of 
gonadorelin, and the largest increase was recorded when the dose was raised from 0.05 to 
0.1 mg. However, individual variation seemed to be wide, and one heifer did not respond 
to any of the doses. In addition, some evidence for the existence of an individually variable 
threshold dose was detected, which may explain the very inconsistent results obtained in 
different studies. 
 
Moreover, the preparation of the GnRH product used affects the LH release, probably via 
differences in absorption and product qualities (Martinez et al. 2003). Souza et al. (2009) 
investigated the LH response after administration of 0.05 mg and 0.1 mg of four different 
gonadorelin products (Cystorelin®, Ovacyst®, Factrel® and Fertagyl®) given on Day 7 
after the last GnRH of the Ovsynch programme to dairy cows. No difference in AUC, time 
to LH peak and LH peak concentration among the products was noticed, and the pooled 
data showed that doubling the dose of GnRH doubled the peak release of LH, and AUC 
was increased by about 80%. The ovulatory response after Factrel® given during the luteal 
phase was significantly less in comparison with the response to other products. Similarly, 
Martinez et al. (2003) compared 0.1 mg of three different gonadorelin formulations 
(Cystorelin®, Fertagyl® and Factrel®) administered intramuscularly to dairy cows and 
beef heifers on Day 6 or 7 after ovulation. Cystorelin® released significantly more LH 
than the other two products did. The mean and mean peak LH values increased as 
compared with the others, as did the ovulation rate in dairy cows, but not in beef heifers. 
Furthermore, Palasz et al. (1989) reported differences in LH release following a 0.1 mg 
dose of two different gonadorelin products (Cystorelin® and Factrel®). The LH peak 
values were not different, but the total secretion was increased in animals administered 
with Cystorelin® in comparison with Factrel®. In an estrus synchronization protocol, 
where PG was given seven days after the first GnRH, and followed 48 h later with another 
GnRH treatment, synchronization rate, double-ovulation rate, conception rate and 
pregnancy loss were similar for 0.05 and 0.1 mg doses of gonadorelin, but the cost of 
treatment was significantly altered (Fricke et al. 1998). 
 
All the studies described above investigated effects of an intramuscular administration of 
gonadorelin. In a recent study, intrauterine administration of 0.2 mg of gonadorelin was 
compared with an intramuscular administration of 0.1 mg of gonadorelin in dairy cows 
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(Bas et al. 2014). Induction of ovulation in response to gonadorelin given 48 h after PG 
occurred in all animals after intramuscular injection (8/8), but not in every animal after 
intrauterine administration (6/9). In comparison, only two untreated control cows (2/8) 
ovulated within 48 h. 
 
In conclusion, increasing the intramuscular dose of GnRH above 0.1 mg of gonadorelin in 
an attempt to release more LH during any stage of the estrous cycle does not increase the 
benefit of the GnRH treatment, but does increase the cost of the treatment. The release of 
LH after GnRH is best evaluated using AUC (area under the LH curve). The preparation of 
the GnRH product may affect LH release. 
 
2.4.3. LH 
 
Several reports have been published concerning the connection between LH and induced 
or physiological short estrous cycles, but in almost all of them no differences between 
short and normal length estrous cycles were reported. Mean peak serum LH levels and 
AUC before, during or after estrus were similar when comparing physiological short 
estrous cycles and subsequent normal estrous cycles (Ramirez-Godinez et al. 1982b). 
Differences in LH secretion pattern were not studied, but LH deficiency was concluded not 
to be a cause of physiological short estrous cycles. According to Garverick et al. (1988), 
inadequate LH secretion was not a cause of physiological short estrous cycles, as mean 
concentration, amplitude and duration of LH secretion were similar for physiological short 
cycles and normal length cycles. In a more recent study by Bridges et al. (2010), the mean 
LH secretion, AUC and LH peak concentration after 0.1 mg of gonadorelin given 2.25 
days or 1.25 days after PG were similar for induced short and normal length cycles. The 
amount of follicular LH receptors on thecal and granulosal cells in postpartum beef cows 
anticipated to exhibit a short cycle was less than in animals having a normal length cycle 
(Braden et al. 1989). Inskeep et al. (1988) detected a significant increase in the amount of 
LH receptors both on thecal and granulosal cells after progestagen treatment of postpartum 
beef cows in comparison with untreated controls exhibiting physiological short estrous 
cycles. In contrast to those studies, Rutter et al. (1985) reported that changes in the 
concentration of LH receptors in the CL or in large/small luteal cell ratio do not cause 
postpartum short estrous cycles. 
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Regarding attempts to decrease the incidence of physiological short estrous cycles, several 
reports have been published on LH secretion following administration of different 
combinations of progestagens, GnRH and/or PG treatments. In beef cows during post-
weaning period, pre-treatment with norgestomet increased the mean secretion of LH and 
the frequency of LH pulses in comparison with non-treated cows, which mainly exhibited 
physiological short cycles (Garcia-Winder 1986). Cruz et al. (1997) gave PG and 0.1 mg of 
gonadorelin 30 h apart to investigate the LH secretion in both cyclic and anestrous 
postpartum suckling beef cows. Short cycles were more common in anestrous cows at 
resumption of ovarian cyclicity (85%) than in cyclic (23%) cows, and cows with a short 
luteal phase had a significantly lower peak amplitude (98.0 vs. 142.5 ng/ml) and smaller 
AUC (19.0 vs. 28.8) during 4 h in comparison with animals with normal length cycles. 
Troxel and Kesler (1984) used 0.25 mg of GnRH 24 h after progestagen treatment for 
eight days in suckled, postpartum beef cows, or only 0.25 mg of GnRH. As a result, the 
total secretion of LH and LH peak concentration were both significantly less for the GnRH 
group in comparison with the progestagen + GnRH treated group. In non-treated controls 
LH remained low during the experimental period (Troxel and Kesler 1984). Similarly, the 
number of LH pulses released did not decrease with exogenous progesterone given for six 
days to postpartum beef cows exposed to restricted suckling once a day (Mackey et al. 
2000). 
 
In conclusion, preovulatory release of LH did not differ between induced or physiological 
short and normal length estrous cycles. 
 
2.4.4. Basal LH secretion 
 
Basal LH secretion during bovine estrous cycles seems to vary among different studies, 
possibly due to differences in experimental settings, LH analysis methods and/or LH 
pulsatility detection methods (Swanson and Hafs 1971, Zolman et al. 1974, Schallenberger 
et al. 1984, Peters et al. 1994, Cupp et al. 1995, Ginther et al. 1998 and Hannan et al. 
2010). In experiments of Ginther et al. (1998) and Hannan et al. (2010) mean basal LH 
secretion (approximately 0.3 ng/ml) was much less than in the earlier studies mentioned 
above. Ginther et al. (1998) investigated early luteal phase and Hannan et al. (2010) the 
entire estrous cycle from one ovulation to another. Significant variation in the baseline LH 
values (between 0.9 and 2.0 ng/ml) among animals has been reported (Swanson and Hafs 
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1971). Although basal LH secretion was not affected by the stage of the luteal phase, the 
number of LH peaks or pulses was. During early luteal phase, fewer LH peaks occurred in 
comparison with the phase of luteal regression and proestrus, and during mid and late 
luteal phases even fewer LH peaks occurred in comparison with during early luteal phase 
(Schallenberger et al. 1985). The number of LH peaks during early luteal phase was 
reported to be 7 per 12 h (Schallenberger et al. 1985), 13 per 24 h on Day 2 after 
behavioural estrus (Peters et al. 1994), and 4.9 per 12 h on Day 5 after behavioural estrus 
(Cupp et al. 1995). Another parameter used for LH peak analysis is the mean inter-pulse or 
inter-peak interval (Schallenberger et al. 1984, Walters and Schallenberger 1984). 
Additional discrepancies in results might be caused by diurnal variation in basal LH 
secretion reported in some studies (Swanson and Hafs 1971, Hannan et al. 2010). Swanson 
and Hafs (1971) reported higher basal LH values in the morning and in the afternoon and 
Hannan et al. (2010) in the morning on Days 5 to 9 after ovulation, but not on Days 10 to 
14. 
 
In conclusion, the number of LH peaks or pulses is affected by the stage of the luteal 
phase. In addition to differences in LH analysis methods, experimental settings and LH 
peak detection methods, basal LH secretion varied diurnally in some studies. 
 
2.4.5. FSH 
 
Garverick et al. (1988) and Schrick et al. (1993), for beef cattle, reported no difference in 
FSH secretion for physiological short estrous cycles and norgestomet-treated normal 
length cycles. Similarly, Garcia-Winder et al. (1986) report no difference in FSH 
concentration in postpartum beef cows treated or not treated with norgestomet. They 
concluded that a threshold secretion of FSH is needed for follicular development. Only 
according to Ramirez-Godinez et al. (1982b) were serum FSH levels for four days before 
ovulation lower in physiological short cycles than in the subsequent, second postpartum 
cycle. The authors suggested further studies to establish whether FSH has a role in 
initiating physiological short estrous cycles. The amount of FSH receptors on granulosal 
cells was similar for physiological short estrous cycles and norgestomet-treated controls 
(Inskeep et al. 1988). In conclusion, there is no evidence that changes in FSH secretion 
cause physiological short cycles. 
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2.5. Uterus and short estrous cycles 
 
2.5.1. Endometrial expression of progesterone, estrogen-α and oxytocin receptors and 
cyclo-oxygenase-II 
 
Endometrial hormone receptors can be investigated in several ways. Before the advent of 
the polymerase chain reaction (PCR), methods included were radio-receptor analysis of 
tissue homogenates (Zelinski et al. 1982, Zollers et al. 1993, Mann and Lamming 1994, 
Leung and Wathes 2000) and immunohistochemistry (IHC) of tissue slices (Boos et al. 
1996, Boos 1998, Dall`Aglio et al. 1999, Kimmins and MacLaren 2001). Samples for 
analysis were collected at slaughter, or taken as biopsies from live animals. Particularly 
when repeated samples are needed, transcervical biopsy is a good option; even repeated 
biopsies taken at the end of the estrous cycle do not shorten the luteal phase via premature 
release of PGF2α (Mann and Lamming 1994). 
 
Steroid receptors are nuclear receptors, and their action is mediated via slow-acting (i.e. 
hours) genomic responses, but fast-acting (i.e. seconds or minutes) non-genomic responses 
have been suggested to exist (reviewed by Stormshak and Bishop 2008). Estrogen receptor 
(ER) is present in two different forms, ERα and ERβ, which differ in their DNA binding 
affinity (Stormshak and Bishop 2008). They are found in different tissues and cells 
(Stormshak and Bishop 2008). Also progesterone receptor (PR) occurs in two different 
forms, PR-A and PR-B, in different tissues and in different ratios: in cattle, PR-A is 
dominant in the ovarian and uterine tissue and PR-B in the mammary gland tissue 
(Stormshak and Bishop 2008). In contrast, only one oxytocin receptor (OR) gene has been 
found (reviewed by Ivell et al. 2000). Before puberty, the expression of uterine OR is 
constitutive, low to moderate, and OR also exists in the foetal uterus during the late third 
trimester prior to birth, if not earlier (Fuchs et al. 1998). Before puberty there is no 
circulating progesterone present, but small concentrations of estrogen (2 to 3 pg/ml) occur, 
allowing the expression of OR (Fuchs et al. 1998). In these pre-pubertal animals the 
endometrium was though not capable to release PGF2α in response to oxytocin, most 
probably due to lack of COX-II expression (Fuchs et al. 1988). At puberty OR was 
suppressed due to the changing hormonal milieu (Fuchs et al. 1998). In ovariectomized 
cows without effects of steroids, OR concentration was relatively high, and unable to 
release PGF2α as a response to oxytocin (Mann et al. 2001). Similarly, in vitro OR was 
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spontaneously up-regulated in the absence of hormonal stimulus, suggesting that in vivo 
regulation of OR is mainly inhibitory (Leung and Wathes 2000). 
 
2.5.1.1. Progesterone, estrogen and their endometrial receptors 
 
The uterus is a target organ for the ovarian secretion of progesterone and estrogen, and 
many studies have been conducted to investigate the cyclical relationship and uterine 
dependency on steroids. In ovariectomized cattle, the expression of ER and PR was 
constitutive, and treatment with exogenous estrogen or progesterone respectively increased 
and decreased the expression of their own receptors (Kimmins and MacLaren 2001). Boos 
et al. (1996), Dall`Aglio et al. (1999) and Robinson et al. (2001) among others, reported 
that the follicular phase (estrogen) promoted endometrial PR and ER synthesis, and luteal 
phase (progesterone) down-regulated them. Also in the oviduct the progesterone phase 
inhibited both ER and PR (Valle et al. 2007). On the other hand, during superovulation 
treatment the concentration of blood estrogen and progesterone were clearly higher than 
during a natural estrous cycle, but no effect on the expression of PR and ER in oviducts of 
heifers was noticed (Valle et al. 2007). Both endometrial ER and PR were maximally 
present during or immediately after estrus, and concentrations declined during the 
subsequent luteal phase (Kimmins and Maclaren 2001). ER concentration was maximal at 
metestrus, i.e. Days 1 to 3 after ovulation, and was down-regulated between Days 7 to 17 
after ovulation (Kimmins and MacLaren 2001). Concentration of PR was maximal during 
metestrus and early diestrus, i.e. Days 1 to 6 after ovulation, and down-regulated as the 
diestrus proceeded (Kimmins and MacLaren 2001). Moreover, Okumu et al. (2010) 
reported significantly higher ERα and PR expression on Days 5 and 7 after estrus in 
comparison with Days 13 and 16. 
 
In addition to the above-mentioned time-specific changes, ER and PR undergo spatial 
changes in the bovine uterus, which can further complicate the interpretation of results. ER 
was expressed in all layers of the endometrium during estrus, in deep glands during the 
whole estrous cycle, and in increased amounts in the luminal epithelium during mid-luteal 
phase (Robinson et al. 2001). PR was expressed mostly in the stroma, and the expression 
was maximal during estrus and early luteal phase (Robinson et al. 2001). According to 
Boos et al. (1996), surface epithelial cells exhibited at least low staining for ER through 
the whole cycle, but increased intensity was recorded between Days 8 and 15 after 
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behavioural estrus (= Day 1). For glands and stroma, maximal staining intensity for ER 
occurred at estrus, and minimal staining on Day 15. At estrus PR was still low on the 
endometrial surface and in glandular epithelium, reaching its maximum on Day 8 after 
behavioural estrus (Day 1), and starting to decline subsequently (Boos et al. 1996). Similar 
results were obtained by Meikle et al. (2001): maximal mRNA results for ER and PR 
occurred around estrus, and both started to decrease on Day 5 after the standing estrus. 
According to a review by Robinson et al. (2008), this timing of maximal expression of PR 
in the endometrium might be related to the relationship between adequate amounts of 
progesterone secretion and embryonic development at the early luteal phase. In early 
embryonic deaths of cattle, inadequate progesterone secretion changed endometrial 
hormone receptor concentrations, and thus indirectly affected the uterine secretion of 
embryo-supporting histotroph, embryo development and maternal recognition of 
pregnancy (Lonergan 2011). During late diestrus an up-regulation of ER in the endometrial 
surface or glandular epithelial cells was noted (Boos et al. 1996). This was thought to be 
important for the initiation of luteal regression via the OR because almost no PR in the 
endometrial surface or glandular epithelial cells was present on Days 15 and 19 after 
behavioural estrus (Day 1) in non-pregnant cows, but the amount of ER was highest 
between Days 8 and 15 (Boos et al. 1996). 
 
In pregnant animals on Day 16 after ovulation, ER was present in shallow endometrial 
glands, and absent in non-pregnant animals on that day, which was suggested to be 
associated with interferon-τ (INF-τ) induced support for the embryo via effects on 
histotroph secretion (Kimmins and MacLaren 2001). In another study on Day 16 there was 
no difference between pregnant and cyclic cows: ER was equally present in luminal 
epithelium and glands (Robinson et al. 1999). According to Okumu et al. (2010), ERα was 
detected in all layers of endometrium, myometrium and stroma. ERα was unaffected by 
the pregnancy status, but ERβ was up-regulated between Days 5 and 7, and remained high 
until Day 16 (Okumu et al. 2010). Exogenous progesterone significantly shortened this up-
regulation (high until Day 13).  The expression of PR in luminal epithelium and superficial 
glands decreased to a low level between Days 7 and 13 both in pregnant and non-pregnant 
heifers, and was still low on Day 16 (Okumu et al. 2010). This decrease in expression was 
significantly more pronounced in pregnant heifers than in cyclic ones, and was hastened by 
exogenous progestagen. According to Robinson et al. (1999), PR was equally present in 
the endometrial stroma of non-pregnant and pregnant cows on Day 16. In contrast, when 
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PG and GnRH were given either 60 h or 36 h apart to early diestrous beef cows, on Day 
15.5 after treatment with GnRH (= Day 0) a reduction in the staining intensity of 
endometrial PR in the deep glandular epithelium was detected (Bridges et al. 2012). On 
Day 15.5, the amount of IFN-τ from embryos transferred on Day 7 was similar between 
groups, as was also the mRNA concentration of OR and PR (Bridges et al. 2012). 
 
In conclusion, the cyclical expression of endometrial ER and PR is cell-specific and 
temporal, regulated by progesterone and estrogen, and possibly connected to OR up-
regulation at luteal regression. During the early luteal phase, i.e. prior to Day 16, the uterus 
seems to prepare for pregnancy. The actual differentiation between non-pregnancy and 
pregnancy takes place subsequently. 
 
2.5.1.2. Up-regulation of endometrial oxytocin receptor 
 
In early pregnant cattle at the time of maternal recognition of pregnancy, luteal regression 
needs to be prevented via release of foetal IFN-τ, which has a direct suppressive effect on 
the translation of OR and ER (Robinson et al. 2001). Endometrial OR was clearly down-
regulated during the first week after ovulation (Ivell et al. 2000), both in luminal 
epithelium and superficial glands, and stayed low, probably due to progesterone acting 
directly on PR and indirectly on OR (Robinson et al. 2001). According to Mann et al. 
(2001), only progesterone, not estrogen, was needed in ovariectomized cows to induce 
oxytocin responsiveness, i.e. release of PGF2α measured as PGFM. Without release of IFN-
τ, endometrial OR concentration in dairy cows started to rise from low concentrations prior 
to first PGF2α release, to reach five-fold peak concentration only after luteal regression was 
complete (Mann and Lamming 2006). 
 
The exact factors behind OR up-regulation are still not completely understood. Robinson 
et al. (2001) proposed two possible causes. First, PR during the luteal phase lost its 
dominance via down-regulation due to progesterone acting on its receptors (Robinson et al. 
2001). Exogenous progesterone supplementation during early luteal phase hastened the 
down-regulation of PR in superficial glands and luminal epithelium (Okumu et al. 2010). 
Inhibition of OR by progesterone (progesterone block) was suggested to occur in sheep by 
McCracken et al. (1984). The down-regulation of PR was not a sufficient stimulus alone, 
and secondly, but less probably according to Robinson et al. (2001), estrogen might have 
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acted via ER to up-regulate OR. In the luminal epithelium ER significantly increased in 
non-pregnant cows on Days 16 to 18 after estrus (Robinson et al. 2001) or on Days 14 or 
16 after ovulation depending on the estrous cycle length (Kimmins and MacLaren 2001). 
In non-pregnant cows ER were not present on Day 16 (Robinson et al. 1999) or Day 18 
after estrus (Kimmins and MacLaren 2001, Robinson et al. 2001). 
 
On the other hand, according to Robinson et al. (2001), the initial up-regulation of OR on 
the luminal epithelium on Days 16 to 17 (in some animals as early as on Day 14) was not 
preceded by changes in ER or PR expression, and the up-regulation of ER between Days 
16 and 18 in non-pregnant cows occurred after up-regulation of OR. There was no 
difference in ER or PR between pregnant and non-pregnant cows on Day 16, and 
inhibition of OR up-regulation in pregnant animals was probably unrelated to the 
expression of ER or to the maintenance of PR (Robinson et al. 1999). The item of evidence 
against the role of ER in priming the luteal regression was that in cattle the OR promoter 
region has an interferon response element (IRE), but no estrogen response element (ERE), 
suggesting that estrogen may have used steroid receptor cofactors (SRC), such as SRC1e, 
and ERE half sites to achieve the estrogenic effect on OR (Telgmann et al. 2003). 
 
Several other theories for causes of OR up-regulation have been suggested. Leung and 
Wathes (2000) concluded that both positive and negative modulators for OR expression 
exist, but the primary regulator was not estrogen, which if present, could speed up the up-
regulation via ER. Leung and Wathes (2000) also concluded, “local factors from the 
endometrium are required to regulate oxytocin receptor expression in the endometrium via 
interaction with the oestrogen receptor”. In a review by Stormshak and Bishop (2008) it 
was assumed that estrogen up-regulated and progesterone down-regulated the uterine OR, 
but the overall situation might have been more complex. Goff (2004) stated that ovarian 
steroids were needed for luteal regression, but their role was still somewhat unclear. A 
review by Ivell et al. (2000) concluded that steroids have not been proved to have any 
direct effect on the OR gene or OR protein, but progesterone seemed to have an indirect, 
paracrine and inhibitory effect on the OR gene. Another review suggested that the effect of 
estrogen is modulatory, and progesterone has a direct effect (Oruda et al. 2002). This effect 
of progesterone on oxytocin responsiveness could be mediated via post-receptor signalling 
pathways and/or enzymes involved in the prostaglandin synthesis (Mann et al. 2001). 
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Morover, during short estrous cycles, the premature loss of endometrial progesterone 
dominance and/or increased concentration of endometrial OR were assumed to cause 
premature PGF2α release (Zollers et al. 1993). On Day 5 after ovulation, endometrial PR 
concentration in short cycle animals was significantly less than in normal cycle animals, 
and endometrial OR concentration in short cycle animals was significantly higher than in 
normal cycle animals (Zollers et al. 1993). Estrogen levels prior to ovulation were assumed 
to determine the length of the subsequent progesterone dominance, i.e. luteal phase, 
through altered levels of PR expression (Zollers et al. 1993). At the time of luteal 
regression during short cycles, high concentrations of endometrial OR were present, and 
peaks of oxytocin and PGFM coincided, allowing the luteal regression to be initiated 
(Hunter 1991). 
 
In conclusion, for up-regulation of OR, the suppressive role of progesterone and PR is 
acknowledged, but the roles of estrogen and ER remain unclear. Ovarian steroids are 
needed and both positive and negative modulators of OR up-regulation are assumed to 
exist. Differences in results of all studies using IHC, radioactive competitive binding 
assay, and/or QPCR when analysing endometrial receptors, may be due to different 
sensitivities of the methods, or existing or lack of true differences between induced and 
physiological short estrous cycles. 
 
2.5.2. Prostaglandin F2α 
 
In the initiation of luteal regression, the most important event is the up-regulation of OR, 
which in turn allows the endogenous release of PGF2α (mini-review by Goff 2004). 
Arachidonic acid, derived from cell membrane phospholipids, is enzymatically converted 
to prostaglandins. First prostaglandin G/H synthase (PGHS), known as cyclooxygenase 
(COX), produces PGH2. Two different COX enzymes exist: COX-1 (PGHS1, constitutive) 
and COX-2 (PGHS2, inducible), and PGH2 is further converted to PGE2 or PGF2α (Goff 
2004). It seems that most prostaglandin synthesis in the bovine endometrium is mediated 
by COX-II (Parent et al. 2003) because no expression of mRNA for COX-I was present 
during the bovine estrous cycle (Arosh et al. 2002). 
 
COX-II was expressed at low and high levels between Days 1 to 12 and 13 to 21, 
respectively (Arosh et al. 2002). To produce PGF2α, PGH2 is further converted to 
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prostanoids by three possible synthase-enzymes: PGD 11-ketoreductase (from PGD2), 
PGH 9-11-endoperoxidase (from PGH2) and PGE 9-ketoreductase (from PGE2). The latter 
is identical to 20α-HSD, which belongs to an aldo-ketoreductase family (AKR1C; Goff 
2004). Also another aldose-reductase enzyme, AKR1B5, was strongly expressed in the 
bovine endometrium at the time of luteal regression (Madore et al. 2003). Its peak 
expression occurred around peak progesterone concentrations, i.e. Days 12 to 18 (Madore 
et al. 2003). AKR1B5 synthesized PGF2α from PGH2, and locally lowered progesterone 
concentrations via degradation (Madore et al. 2003). PGE-synthase (PGES) produced 
PGE2, and in comparison with PGF2α, showed a different endometrial expression pattern: 
Days 1 to 3 moderate, Days 4 to 12 low and Days 13 to 21 high (Arosh et al. 2002). 
During the high expression period PGES was significantly correlated with COX-II mRNA 
expression (Arosh et al. 2002). During luteal regression the pulsatile release pattern of 
PGF2α made the CL sensitive to PGF2α, and prevented desensitization (reviewed by Okuda 
et al. 2002). In pregnant animals the basal levels of PGF2α were higher than in non-
pregnant ones. The maximum concentration of PGF2α occurred for 2 to 3 days during 
luteal regression and after it, i.e. during follicular phase and estrus (Okuda et al. 2002). In 
six dairy cows during a 10 h sampling period, 2.2 ± 0.5 episodes of PGF2α were released 
on average prior to luteal regression, and each episode took 4.0 ± 0.4 h on average (Mann 
and Lamming 2006). 
 
Another theory concerning the connection between the endometrium and PGF2α or PGE2 
exists: during the luteal phase, i.e. during high progesterone, prostaglandins significantly 
reduce the arterial blood flow to the endometrium, leading to local hypoxia and 
remodelling of the endometrium (Krzymowski and Stefánczyk-Krzymowska 2008). The 
increased mass of the uterus during the luteal phase is due to water retention via increased 
oncotic pressure and increased albumin retention. Albumin may bind PGF2α and its 
metabolites. Remodelling releases PGF2α from endometrial cells to the lymphatics. PGF2α 
is further transferred via a retrograde countercurrent system from the venous blood to the 
arterial blood, and in the ovary PGF2α may induce luteal regression. During early luteal 
phase this system is supposed to prevent premature luteal regression and to protect early 
pregnancy. Pulsatile elevations of PGF2α measured in the peripheral blood are only a 
reflection of remodelling events occurring in the endometrium, and only very small 
amounts of PGF2α are needed for luteal regression.  When estrogen levels are high PGE2 is 
secreted and arteries are relaxed. Oxytocin pulses secreted by the ovary or the 
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hypothalamus induce varying amounts of uterine contractility depending on the amount of 
endometrial OR, and the contractions put pressure on uterine tissues. Increased pressure 
then causes blood and lymph to flow more (Krzymowski and Stefánczyk-Krzymowska 
2008). 
 
Copelin et al. (1987) proved that an intact uterus was needed for PGF2α-induced luteal 
regression, and short estrous cycles could be prevented with hysterectomy. As a response 
to oxytocin injection, PGF2α was released as early as on Day 5 in postpartum beef animals 
expected to have a short cycle, but not in animals having a normal length cycle (Zollers et 
al. 1989). In vitro on Day 5, PGF2α was secreted from endometrium in animals expected to 
have short estrous cycles (Zollers et al. 1991). The CL during short cycles was not more 
sensitive to PGF2α than during normal length cycles (Copelin et al. 1986, Garverick et al. 
1988). Basal serum oxytocin and PGFM concentrations were significantly elevated 
throughout the cycle in postpartum animals having cycle lengths less than 17 days in 
comparison with animals with normal length cycles (Peter et al. 1989). The release of 
oxytocin and PGFM were related (Peter et al. 1989). Embryo flushing medium on Day 6 in 
short cycle beef animals contained significantly more PGF2α in comparison to normal 
length cycles (Schrick et al. 1993), and this difference tended to be correlated with embryo 
quality on that day. The PGF2α secretion on Day 5 in postpartum short cycle animals was 
similar to secretion during luteal regression at the end of normal length cycles on Day 16 
(Zollers et al. 1989). Taponen et al. (2003) showed that luteal regression in dairy heifers 
during induced short estrous cycles was caused by a premature release of PGF2α, which 
resembled the release during normal, spontaneous luteal regression. 
 
In conclusion, endometrial up-regulation of OR is followed by release of PGF2α and leads 
to luteal regression. According to another theory, this release of PGF2α may only be a 
reflection of endometrial remodelling events. The release of PGF2α prior to luteal 
regression occurs both during physiological and induced short estrous cycles. 
 
2.6. Estradiol concentration in peripheral blood 
 
The estradiol secretion at estrus in postpartum short estrous cycles was significantly less 
than in progesterone-treated controls (Garcia-Winder et al. 1986, Garverick et al. 1988). In 
beef cows, estradiol secretion significantly increased three days before estrus in 
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postpartum normally cyclic animals in comparison with animals exhibiting short cycles 
(Schrick et al. 1993). The number of cows in standing estrus was increased with 
norgestomet treatment (Sheffel et al. 1982). In postpartum beef cows anticipated to exhibit 
a short cycle, the estradiol concentration of the follicular fluid was four times lower than in 
animals having a normal length cycle (Braden et al. 1989). The significantly increased 
concentration of estradiol in follicular fluid of norgestomet-treated beef cows in 
comparison with untreated animals exhibiting physiological short estrous cycles was 
reported by Inskeep et al. (1988). In a study with beef cattle by Bridges et al. (2010) the 
peak concentration of estradiol during proestrus was significantly lower in animals having 
a shorter interval between PG and GnRH treatments (1.2 d vs. 2.2 d), as was also the 
estradiol concentration around ovulation (Days -1.9 to 0). The peak ovulatory 
concentration of estradiol in most short cycle cases (4/5) was less than 10 pg/ml, and if the 
concentration of estradiol was over 10 pg/ml, most cows (10/11) had a cycle of normal 
length (Bridges et al. 2010). 
 
On the other hand, the size of the preovulatory follicle, above or below 10 mm, at induced 
luteal regression did not lead to differences in estrogen secretion, because follicles were 
allowed to grow and ovulate spontaneously (Robinson et al. 2005). In another study, the 
increasing follicular size was associated with increasing blood estradiol concentration 
(Atkins et al. 2008). Secretion of estradiol could be an important determinant of 
physiological maturation of follicles and initiation of estrus, but the absolute diameter of 
the follicle or the magnitude of GnRH-induced LH secretion was thought to be less 
important (Atkins et al. 2008). Mann and Lamming (2000) postulated that low 
preovulatory levels of estradiol could be the cause of postpartum short estrous cycles via 
impaired OR inhibition. Thus premature luteal regression during postpartum short cycles 
was not due to lack of progesterone priming. Endometrial OR levels could be decreased 
with exogenous estradiol in the absence of progesterone, and the degree of OR expression 
was related to the amount of estradiol secreted during estrus (Mann and Lamming 2000). 
 
In conclusion, the amount of estradiol secreted is not related to the size of the preovulatory 
follicle if follicles can ovulate spontaneously. When ovulation is induced with GnRH, 
decreasing the length of proestrus also decreases the secretion of estradiol around estrus. 
Secretion of estradiol is also decreased during physiological short cycles, and may be 
increased with exogenous progesterone. 
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2.7. Ovulation induction with gonadotropin releasing hormone and the size of the 
ovulatory follicle 
 
During Ovsynch or GPG protocol, two doses of GnRH are separated by a single 
administration of PG 6 to 7 days after the first GnRH injection (Wolfenson et al. 1994, 
Twagiramungu et al. 1995).  The first GnRH treatment caused follicular ovulation or 
atresia, thus allowing growth of a new follicular wave within two days. The GnRH 
treatment may be repeated 24 h (heifers) or 48 h (cows) after PG administration to induce 
ovulation of the dominant follicle in 24 to 32 h (Pursley et al. 1994). According to Silcox 
et al. (1995), a combination of PG and 0.1 mg of gonadorelin given 48 h apart was 
ineffective because ovulation in heifers was induced too late (30 to 31 h after GnRH), 
similarly to controls treated with saline (30 ± 6 h). This time interval in cows did not affect 
fertility as ovulation was induced earlier, i.e. 26 ± 1 h after GnRH (Silcox et al. 1995). In a 
study by Martinez et al. (2003), dairy cows ovulated 35.0 ± 2.5 h after 0.1 mg of 
gonadorelin, i.e. somewhat later. 
 
The maximal diameter of the ovulating follicle is influenced by the stage of the estrous 
cycle when synchronizing estrus with GPG (Vasconcelos et al. 1999). During mid-cycle 
(Days 5 to 13) ovulating follicles were smallest. Also the time interval between PG and 
GnRH affected the size of the ovulatory follicle: ovulatory follicles were smaller on the 
day of GnRH administration in dairy cows treated simultaneously with PG and GnRH, in 
comparison with animals treated 24 h apart (Peters and Pursley 2003). The size of the 
ovulatory follicle was reduced 30 % when the time interval between PG and 10 µg of 
buserelin was 40 h rather than of 60 h (Bollwein et al. 2010). In contrast, no difference was 
detected in the ovulatory follicular diameter in beef cattle when the time interval between 
administration of PG and 0.1 mg of gonadorelin was decreased from 2.2 d to 1.2 d or from 
2.25 d to 1.25 d (Bridges et al. 2010).  
 
Follicle size at spontaneous ovulation had no effect on fertility, but small follicles induced 
to ovulate with GnRH reduced blood estradiol on insemination day and decreased the rise 
in and concentration of blood progesterone (Perry et al. 2005). This led to decreased 
pregnancy rate and increased embryonic mortality (Perry et al. 2005). A modified Ovsynch 
programme, where the second GnRH was given 40 h after PG, diminished the size of the 
preovulatory follicles compared with the case for spontaneously ovulating dairy cows 
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(Bollwein et al. 2010). The shortened preovulatory phase could exert a negative effect on 
fertility via a decreased ovulatory follicle size and inadequate follicle development, and 
also decreased luteal blood flow (Bollwein et al. 2010). However, the size of the ovulating 
follicle was not correlated with follicular blood flow (Bollwein et al. 2010). Bridges et al. 
(2010) suggested that follicular characteristics other than size at ovulation were more 
likely to explain the decreased fertility induced by a shortened preovulatory period. They 
thought the most likely cause to be the altered preovulatory concentrations of estradiol and 
progesterone due to a shortened proestrus phase. 
 
In conclusion, the size of the preovulatory follicle is affected by the stage of the estrous 
cycle when inducing luteal regression and ovulation with PG and GnRH. Also decreasing 
the time interval between PG and GnRH administration has an effect on the size of the 
preovulatory follicle, and may also have negative effects on fertility, possibly via changes 
in estradiol and progesterone concentrations around estrus. 
 
2.8. Peripheral blood progesterone concentration and corpus luteum 
 
Lucy and Stevenson (1986) investigated serum progesterone concentrations following PG 
and 0.1 mg of GnRH or saline given 72 h apart to cyclic dairy cows and heifers. During 21 
days following estrus the progesterone secretion was lower in GnRH-treated animals in 
comparison with saline-treated ones. Progesterone rose more quickly during the first week 
following estrus in animals ovulating spontaneously, compared with animals that ovulated 
after treatment with GnRH (Lucy and Stevenson 1986). Several possible explanations for 
the reduced luteal function were reviewed: a short term depletion of pituitary LH stores (of 
less duration than 12 h) due to extra LH release, an LH surge of shorter duration, fewer 
mitotic divisions in thecal and granulosal cells before LH release and following inadequate 
luteinization, down-regulation of luteal LH receptors, an asynchronious hormonal 
environment at induced ovulation, or a direct GnRH-induced suppression on luteal cells 
(Lucy and Stevenson 1986). However, conception rate was higher in animals receiving 
GnRH compared with animals given only saline. More slowly rising progesterone levels 
were assumed to improve fertility via unknown effects on embryonic survival (Lucy and 
Stevenson 1986).  
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If GnRH was given during proestrus, a less mature follicle ovulated and formed a CL that 
secreted less progesterone at the beginning of the cycle and during mid-luteal phase, thus 
lowering conception rates (Macmillan et al. 2003). According to Macmillan et al. (2003), 
the occurrence of short cycles following hormonal synchronization treatments should be 
taken as a sign of impaired effectiveness, and low doses of GnRH may be a cause of short 
cycles through an abnormal corpus luteum formation. Rutter et al. (1985) compared 
corpora lutea from postpartum cows with a normal cycle with cows having a short cycle: 
CL were heavier in cows having a normal cycle, but LH receptor concentration, 
progesterone production, and the small/large luteal cell ratio were similar on Day 6.5 after 
GnRH treatment. Luteal adenylate cyclase activity, phosphodiesterase activity, weight, 
number of LH receptors, and luteal or plasma progesterone concentrations were reported to 
be similar on Day 5 after estrus in postpartum beef animals having a short or normal cycle 
(Smith et al. 1986). Adenylate cyclase and phosphodiesterase were studied as authors 
hypothesized LH-induced progesterone secretion to be mediated via these enzymes, and 
changes in their activity might have caused short estrous cycles. In studies by Ramirez-
Godinez et al. (1981, 1982b) serum progesterone concentrations declined after Day 6 
following estrus in postpartum beef cows exhibiting a short cycle. 
 
Bridges et al. (2010) also reported a decrease in progesterone concentration during the 
mid-luteal phase of short cycles in comparison with normal length cycles. In a study by 
Bollwein et al. (2010), luteal blood flow was dependent on the time interval between PG 
and GnRH. The highest values were recorded in animals after spontaneous ovulation, and 
significantly lower values occurred when ovulation was induced with 10 g of buserelin 
given 40 h after PG. However, no correlation either between follicular size and follicular 
blood flow or between CL size and CL blood flow existed, but the size of the ovulating 
follicle and the size of the CL on Day 7 after ovulation were significantly, positively 
correlated. The follicular blood flow was increased in animals ovulating spontaneously, as 
compared with hormone treated animals induced to ovulate with 10 g of buserelin given 
40 h after PG. If ovulation was induced 60 h after PG with 10 g of buserelin, there was 
no significant difference between the groups (Bollwein et al. 2010). The authors suggested 
that the optimal time interval between PG and GnRH administration might be cow-
specific, and a shortened time prior to ovulation decreased both follicular and luteal blood 
flow (Bollwein et al. 2010). 
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In conclusion, induction of ovulation with GnRH decreases progesterone secretion and 
leads to a slower rise in progesterone level during early and midluteal phase. Shortened 
proestrus also affects follicular and luteal blood flow. 
 
2.9. Peripheral blood progesterone, basal LH secretion and follicle size 
 
The size of the ovulating follicle is linked to other hormonal changes around estrus. In 
dairy cows, the dominant follicle before ovulation was significantly bigger when luteal 
regression and ovulation were induced during early diestrus than during late diestrus 
(Vasconcelos et al. 1999). The average progesterone concentration at the time of 
treatments was significantly lower during early diestrus than late diestrus (Vasconcelos et 
al. 1999). In a study by Lüttgenau et al. (2011), lowered progesterone concentration in 
dairy cows during the luteal phase was linked to the increased size of the first wave 
dominant follicle, reported earlier in dairy heifers by Adams et al. (1992), and in beef cows 
by Pfeifer et al. (2009). Lüttgenau et al. (2011) concluded this to be caused by an increase 
in LH pulse frequency during Days 9 to 15 after ovulation, but LH concentrations were not 
analyzed. Follicular dynamics were suggested to be the cause behind increased LH pulse 
amplitude around Days 7 to 12 after behavioral estrus, because this could not be explained 
by changes in progesterone or estradiol levels (Cupp et al. 1995). Increased LH pulse 
frequency and mean of all LH concentrations coincided with follicular wave deviation at 
around Days 2 and 12 after ovulation (Ginther et al. 1998). Pfeifer et al. (2009) reported a 
significant increase in basal and mean LH concentrations in animals with lowered 
progesterone concentration during dominant follicle growth. Decreased or increased 
progesterone concentration, respectively, increased or decreased the LH pulse frequency 
within 6 h (Bergfeld et al. 1996). A larger ovulating follicle resulted in a larger CL, with a 
subsequent increase in progesterone secretion (Pfeifer et al. 2009). This increase in luteal 
size and progesterone concentration was, however, not reported by Lüttgenau et al. (2011). 
The cause for the reduction in the size of the dominant follicle is a progesterone-induced 
decrease in LH concentration (Ginther et al. 2001a, 2001b), and LH and progesterone 
oscillations are positively and temporally related (Hannan et al. 2010). 
 
In conclusion, mean progesterone concentration affects follicle size via differences in LH 
pulse frequency and basal LH secretion.  
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3. AIMS OF THIS THESIS 
 
 
The research for this thesis was carried out to elucidate possible mechanisms behind PG 
and GnRH induced short estrus cycles in cyclic dairy cows and heifers. The specific aims 
of different projects were as follows: 
 
I To investigate whether the cycle day (early vs. late diestrus) affects the 
incidence of induced short estrus cycles or the size of the preovulatory 
follicle. Also to analyze the preovulatory peak of LH and postovulatory, 
basal LH release during induced short estrus cycles in comparison with 
spontaneous ovulation and normal length estrus cycles in cyclic dairy heifers. 
 
II To investigate whether the dose of gonadorelin (low vs. high) affects the 
preovulatory release of LH, the size of the ovulating follicle or the incidence 
of short estrous cycles in cyclic dairy heifers. 
 
III To investigate whether the time interval (0 vs. 24 h) between PG and GnRH 
administration affects ovulation rate, follicle size at ovulation and the 
incidence of induced short estrus cycles in cyclic dairy heifers and cows. 
 
IV To investigate whether endometrial expression of the receptors estrogen-α, 
progesterone, oxytocin and the enzymes cyclo-oxygenase-II and 20α-
hydroxysteroid-dehydrogenase on Days 2 and 5 after ovulation differ 
between normal length estrous cycles and induced short estrous cycles in 
cyclic dairy cows. Also to investigate whether follicle size and estradiol 
secretion at estrus differ between normal and induced short estrus cycles.  
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4. MATERIALS AND METHODS 
 
An overview of materials and methods is presented in this section, and detailed 
information can be found in the original publications (I-IV). 
 
4.1. Animals 
 
Healthy, normally cyclic dairy heifers and highly productive dairy cows were used. All 
experiments took place at Viikki Research Farm, University of Helsinki, Finland, between 
years 2000 and 2007. Heifers (Experiments I to III) were loose housed, and cows 
(Experiments III and IV) were kept stanchioned. Animals were fed grass silage, 
concentrate and straw (heifers) or hay (cows) according to Finnish standards. Most animals 
were Finnish Ayrshires, only two heifers (Experiment III) and one cow (Experiment IV) 
were Holstein-Friesians. Number of animals in each experiment, age of heifers at the 
beginning of the experiment, and the experimental period are shown in Table 4.1.A. 
 
 
Table 4.1.A. Number of dairy heifers and cows, heifer age at the beginning of each experiment, 
and the experimental period (month/year) in Experiments I to IV. 
 
Experiment 
number 
Number of cases 
Heifer age at the 
beginning of 
experiment 
Experimental  period 
(month/year) 
I heifers 19 12 to 21 months 9/2000 - 2/2001 
II heifers 25 11 to 14 months 12/2002 - 3/2003 
IIIa heifers 21 13 to 18 months 1 - 3/2004, 2 - 6/2005 
IIIb cows 26 - 11/2000 - 6/2001 
IV cows 14 - 4 - 6/2005, 1 - 5/2006 
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4.2. Experimental designs 
 
Animal welfare was taken into account when planning the experimental settings, and all 
experiments were approved by the Ethics Committee of the University of Helsinki or by 
the Animal Experiment Board at the University of Helsinki. Animals were first assigned 
randomly into the treatment groups. After at least one unmanipulated estrous cycle animals 
could be subjected to another treatment. In all experiments the intramuscularly 
administered GnRH was 0.1 mg of gonadorelin (Fertagyl
®
 0.1 mg/ml, Intervet 
International, Boxmeer, The Netherlands), with the exception that a 0.5 mg dose was used 
also in Experiment II. Luteal regression was induced with an intramuscular administration 
of an agonistic analogue of prostaglandin F2α: 0.15 mg of dexcloprostenol (Genestran
®
 75 
µg/ml, Vetcare Ltd, Salo, Finland) was used in all experiments except in IIIb, where 0.5 
mg of cloprostenol (Estrumat 0.25 mg/ml, Mallinckrodt Veterinary Ltd., Harefield, 
Uxbridge, UK) was used instead. All treatments and samplings were performed by the 
same operator at the same time of day. 
 
In all experiments, the estrus synchronization procedure was the same: the cyclic status of 
each animal was determined using a transrectal ultrasound examination, and estrus was 
induced with a single dose of PG. Starting from the first (Experiments I, III, IV) or second 
(Experiment II) day after PG administration, the animals were examined daily using 
transrectal ultrasonography to monitor the occurrence of ovulation. The second luteal 
regression was thereafter induced with PG on the following days after ovulation (= Day 0): 
Experiment I - Day 7 or Day 14; Experiments II and III - Day 7; Experiment IIIb - Day 8, 
9 or 10; and Experiment IV - Day 8. Subsequently, the protocol continued differently in 
each experiment. 
 
4.2.1. Treatment groups 
 
Experiments I, II and IIIa included two different treatment groups, Experiment IIIb three 
different groups, and Experiment IV only one treatment group. In Experiment I, an 
unmanipulated control group was included. Numbers of animals in different subgroups in 
Experiment I to IV are presented in Table. 4.2.1.A. 
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Table 4.2.1.A. Number (n) of animals in different subgroups (D7, D14, C, T500, T100, T0, T24, 
D8, D9, D10) in Experiments I to IV. 
 
 
 
Experiment 
I 
Experiment 
II 
Experiment 
IIIa 
Experiment 
IIIb 
Experiment 
IV 
      
Treatment 
group 
D7: n = 6 
D14: n = 6 
T500: n = 15 T0: n = 23 D8: n = 18 
D9: n = 5 
D10: n = 3 
n = 11 
      
Control 
group 
C: 
n = 7 
T100: 
n = 10 
T24: 
n = 23 
  
 
 
 Experiment I: the 2nd PG was administered either on Day 7 (D7) or on Day 14 
(D14) after ovulation, and GnRH was given 24 h after PG. An unmanipulated 
control group (C) was included, and synchronized with CIDR (CIDR+®, Vetcare, 
Salo, Finland) inserted for nine days. 
 Experiment II: two different doses of gonadorelin were administered 24 h after PG, 
either 0.5 mg (T500) or 0.1 mg (T100). Group T100 served as a control group. 
 Experiment IIIa: PG and GnRH were given at different time intervals, 
simultaneously (T0) or 24 h apart (T24). Group T24 served as a control group. 
 Experiment IIIb: the animals were treated simultaneously with PG and GnRH 
either on Day 8 (D8), Day 9 (D9) or Day 10 (D10) after ovulation. 
 Experiment IV: PG and GnRH were given 24 h apart to all animals. 
 
4.2.2. Blood sampling and treatment manipulations 
 
In Experiments I, II, IIIa and IV blood sampling for plasma progesterone (P4) 
determination began immediately before the 2nd PG administration and continued once 
daily until the 2nd ovulation after the GnRH treatment. The samples were collected into 
heparinized blood tubes (Vacutainer®, Becton Dickinson Vacutainer Systems, Plymouth, 
UK) by vacuum puncture of a tail blood vessel. After immediate centrifugation 
(Experiment I 2200 x g, 10 min; Experiment II 1500 x g, 10 min; and Experiments IIIa and 
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IV 1400 x g, 10 min), the plasma was harvested, frozen, and stored in plastic tubes at –20 
°C until analyzed. Blood samples for LH analysis (Experiment I and II) were treated 
similarly. 
 
In Experiment I, the heifers were treated during early (D7) or late (D14) diestrus with PG 
and GnRH 24 h apart. Follicles thus induced to ovulate were the first and second wave 
dominant follicles, respectively. Blood sampling for hormone determinations began 
immediately before the 2nd PG, and continued once daily during the entire following 
estrous cycle until the next ovulation. In Groups D7 and D14, an indwelling catheter was 
inserted into the jugular vein for LH analysis some hours before the 2nd PG. Frequent 
sampling periods were as follows: beginning immediately before GnRH administration 
and continuing every 30 min for 6 h and on Days 1, 3, and 5 every 10 minutes for 3 h. 
After the last frequent sampling period, the catheters were removed and sampling 
continued once daily from a tail blood vessel. In the control Group C, blood was collected 
once daily for 16 days starting from the day of the CIDR removal. These heifers were 
catheterized for frequent blood sampling as in other groups. Blood sampling started 36 h 
after the removal of the CIDR device, and samples were collected every 30 min for 31 h. 
On Days 1, 3, and 5 after the ovulation, blood samples were taken every 10 min for 3 h as 
in other groups. 
 
In Experiment II, the heifers were administered either 0.5 mg (Group T500) or 0.1 mg 
(Group T100) of gonadorelin 24 h after PG to induce ovulation. Five heifers in both 
groups were catheterized with an indwelling catheter some hours before GnRH 
administration, and blood samples for LH response analysis were collected every 30 min 
beginning one hour before GnRH administration and continued for 6 h after it. 
 
In Experiment IIIa, all heifers were given GnRH either 0 (Group T0) or 24 hours (Group 
T24) after the PG administration. In Experiment IIIb all animals received simultaneous PG 
and GnRH injections on Day 8 (n = 18), Day 9 (n = 5) or Day 10 (n = 3) after ovulation. 
 
In Experiment IV, the cows were given GnRH 24 h after PG. After ovulation, transcervical 
endometrial biopsies were taken on Days 2 and 5. 
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4.2.3. Milk sampling 
 
Whole milk samples for P4 determinations were collected daily in Experiment IIIb beginning 
immediately before the PG and GnRH treatment and continued until signs of next estrus were 
detected. Samples were collected immediately after the morning milking into plastic tubes 
containing a tablet of bronopol, after which they were frozen and stored in the original 
tubes at –20 °C until analyzed. 
 
4.3. Ovarian examinations 
 
In all experiments, ovarian examinations were performed with a real-time B-mode 
ultrasound scanner (Aloka SSD-210DXII, Aloka, Japan) equipped with a 7.5-MHz rectal 
linear array transducer. The ovaries were scanned several times to determine the largest 
cross-section of follicles and/or a CL. By freezing the image, the largest and smallest 
diameters were measured and recorded, and the average diameter was calculated later. The 
central cavities of CLs were measured and recorded in the same way. All follicles equal to 
or larger than 5 to 6 mm were measured. Locations of follicles larger than that were coded 
to follow their growth. Occurrence of ovulation was defined as a sudden disappearance of 
a large follicle between two consecutive ultrasound scans. Day of ovulation (Day 0) was 
the last day when the follicle was intact prior to the subsequent examination showing that 
the follicle had disappeared.  
 
In Experiments I, II, IIIa and IV, transrectal ultrasonographic examinations of the ovaries 
were started 24 h after GnRH administration, and repeatedly performed once hourly 
(Experiment II), every 6 h (Experiments I and IIIa) or every 12 h (Experiment IV) until 
detection of ovulation, and thereafter once daily starting immediately (Experiments I, IIIa 
and IV), or on Day 4 (Experiment II), and continuing until the next ovulation or for at least 
9 d (Experiment I). Possible signs of estrus and metestrous bleeding were recorded daily. 
In Experiment I, daily scanning was continued in all animals in Groups D7 and D14 until 
next ovulation occurred in short cycles, i.e. for at least 9 d, and in normal cycles again 
when signs of estrus were noticed. In Group C ultrasound examinations were started on the 
day of CIDR removal, and continued as in normal cycle animals. In Experiment IIIb, 
ultrasound examinations were performed daily beginning from the day of PG and GnRH 
treatment until the appearance of a new CL, thus confirming luteal regression, ovulation 
47 
 
and development of a new CL. During expected occurrence of short cycles, ultrasound 
examinations were performed daily, and after that normal length cycles were intermittently 
followed up until the next estrus. 
 
4.4. Hormone analyses 
 
4.4.1. Progesterone 
 
The concentration of plasma P4 was measured in one sample per day throughout the 
sampling period in Experiments I, II, IIIa and IV. The measurements were performed by 
radioimmunoassay (RIA) using commercial kits (Coat-A-Count
®
 Progesterone, Diagnostic 
Products Corporation, Los Angeles, USA; or Spectria®, Orion Diagnostica, Orion 
Corporation, Espoo, Finland). The detection limit of both assays was 0.3 nmol/l. In 
Experiment IIIb, the whole milk P4 concentration was measured with RIA using a 
commercial kit (Spectria®, Orion Diagnostica, Orion Corporation, Espoo, Finland) in 
single tubes. Immediately before analysis, the samples were allowed to thaw at room 
temperature. After thawing, they were warmed in +45 °C for 15 minutes and then carefully 
shaken with a single tube vortex for 30 seconds in order to redisperse their fat content. The 
detection limit of the assay was 1.0 nmol/l. Sample type and intra- and inter-assay 
coefficients of variation (CV) are summarized in Table 4.4.1.A. 
 
4.4.2. LH 
 
In Experiment I, peripheral plasma LH concentration was measured once in each sample 
using a RIA method described earlier by Forsberg et al. (1993). The intra- and inter-assay 
CVs for LH, as well as detection limits of the assay, are shown in Table 4.4.2.A. Pulses of 
LH on Days 1, 3 and 5 after ovulation were defined as values above individual basal LH 
values, i.e. peaks, detected according to a skewedness method described earlier by Zarco et 
al. (1984). In summary, mean and standard deviations (SD) of all samples were calculated, 
and samples greater than two SD above the mean excluded. This procedure was continued 
until no further peaks were detected. The mean of remaining values represented the 
average basal secretion of LH in each animal, and values above that were considered to 
represent a significant secretion of LH, i.e. pulses of LH. The LH wave after CIDR  
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Table 4.4.1.A. A summary of progesterone (P4) sample type (blood or milk), intra- and inter-assay 
coefficients of variation (CV, %) and P4 levels for CV calculations (nmol/l) in Experiments I to IV. 
 
Experiment 
number 
Type of P4 
sample 
P4 level for CV 
calculations (nmol/l) 
Intra-assay CV 
(%) 
Inter-assay CV 
(%) 
     
I Blood 4.6 
7.9 
6.1 
4.1 
7.4 
6.4 
II Blood 6.0 6.7 11.4 
10.8 8.3 10.8 
IIIa Blood 16.2 6.9 10.3 
33.1 15.0 12.3 
IIIb Milk 15.9 < 8.5 < 8.5 
IV Blood 8.0 12.3 One assay 
25.1 10.7 One assay 
 
 
removal in Group C was detected similarly, i.e. several consecutive values above 
individual basal level. 
 
In Experiment II, peripheral plasma LH concentrations were measured using a direct 
double-antibody RIA described and validated by Niswender et al. (1969) with the 
following minor modifications. Samples were first incubated with a buffer solution and 
bovine LH antibody (Tucker Endocrine Research Institute, the USA) for 24 h, after which 
a radioactively labelled LH (Bovine LH, Tucker Endocrine Research Institute, the USA) 
was added. Incubation was continued for 48 h, after which a solid-phase second antibody-
coated cellulose suspension (SAC-CEL i.e. Solid Phase Second Antibody Coated 
Cellulose Suspension, IDS Ltd., Boldon, UK) was added to separate bound and unbound 
labels. Incubation was continued for 30 min. After centrifugation (3000 x g, +4 °C, 10 
min) the radioactivity of the solid phase was measured using a gamma counter 
(MiniGamma 1275 Gamma Counter, Wallac). Controls and standards were included, as 
well as quality controls. A standard radioactivity curve for labeled LH was determined for 
concentrations ranging from 16 ng/ml to 0.125 ng/ml by serially diluting the original 
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sample with a buffer. The detection limit of the assay was defined as three SD for 0-
binding values. The intra- and inter-assay coefficients for LH, as well as detection limits of 
the assay, are shown in Table 4.4.2.A. 
 
4.4.3. Estradiol-17β 
 
In Experiment IV, the concentration of peripheral blood estradiol-17β (E2) was measured 
daily throughout the sampling period using a sequential RIA as described by Klein et al. 
(2003). Plasma (0.25 ml) was extracted with toluene; the antiserum used was directed 
against E2-6-carboxymethyloxim (CMO)-BSA. The minimum detectable concentration 
was 2 pg/ml and quality controls were included in each assay. 
 
4.5. Uterine biopsies 
 
In Experiment IV, endometrial biopsy samples were obtained on Days 2 and 5 after 
ovulation. The cows were sedated and epidural anesthesia was induced. The vulva and 
perineum were washed, disinfected, and a 56 cm, sterile, guarded biopsy instrument 
(metallic, home-made with a mechanism corresponding to that of Tru-Cut® biopsy 
instrument,) was introduced via the cervix to either uterine horn, aided by manipulation per 
rectum. Four to five endometrial sections (about 20 mm x 5 mm) were cut on both days. 
One section was incubated in 10% phosphate buffered formalin solution for 24 h at +4 °C 
(tissue-formalin ratio 1:10), and three or four sections were immediately frozen with liquid 
nitrogen and stored at -80 °C until RNA extraction. The formalin-incubated biopsy sample 
was stored for one week in phosphate buffer at +4 °C, after which it was cut longitudinally 
into two sections, dehydrated, embedded in paraffin wax and kept refrigerated until 
immunohistochemistry analysis. 
 
4.6. Immunohistochemistry 
 
In Experiment IV, a microtome (Mikrom HM 400) was used to cut 4-μm sections of the 
biopsy samples, which were mounted on SuperFrost® Plus glass slides (Menzel Glaeser, 
D-38116, Braunschweig, Germany) and dried at +37 °C. Sections were deparaffinized 
with xylene (2 x 5 min) and rehydrated with a graded alcohol series (99%, 95% and 70%, 
2 x 2 min each), and rinsed with running tap water for 5 min. For antigen retrieval,  
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Table 4.4.2.A. The intra- and inter-assay coefficients of variation (CV, %) for luteinizing hormone 
(LH) analysis, CV calculation levels (ng/ml) and the detection limit of the assay (ng/ml) in 
Experiments I and II. 
 
Experiment 
number 
LH level for CV 
calculations 
(ng/ml) 
Intra-assay CV 
(%) 
Inter-assay CV 
(%) 
Detection limit of 
the assay (ng/ml) 
     
I three different 4.6 to 7.5 5.7 to 7.7 0.1 
II 3.7 1.0 to 19.2 19.2 0.025 
 
 
sections were pre-incubated in citrate buffer for 5 min at room temperature, heated in pre-
heated citrate buffer in a microwave oven (560 W, 3 x 5 min), cooled for 20 min, and 
rinsed with running tap water for 5 min. Endogenous peroxidase activity was quenched 
with 0.3% hydrogen peroxide in methanol for 30 min. Thereafter, samples were washed 
with immunohistochemistry (IHC) buffer (phosphate buffered saline and 0.3% Triton X, 
pH 7.2-7.4) for 5 min, drained and incubated with 10% blocking serum to block non-
specific binding sites. For PR, ER and COX-II, 10% horse serum was used for blocking. 
After draining the serum, the samples were incubated with the respective primary antibody 
in a humid chamber at +4 ºC overnight. Primary antibodies for PR (1:500, mouse 
monoclonal IgG2a clone 10A9, dianova-immunotech, Hamburg, Germany), ER (1:200, 
mouse monoclonal IgG2a Ab-8, clone AER311, Lab Vision Corporation, Fremont CA 
94539 USA) and COX-II (1:100, mouse monoclonal IgG clone 33, BD Biosciences 
Pharmingen, Becton, Dickinson and Company) were diluted in IHC buffer. All primary 
antibodies used were validated earlier for use in bovine uterine tissue (Schuler et al. 1999, 
2002, 2006). Negative antibody control for PR, ER and COX-II was mouse monoclonal 
antibody (MsIgG2a, BeckmanCoultier) diluted in IHC buffer (1:100). 
 
On the following day the sections were washed in IHC buffer for 20 min, drained and 
incubated at room temperature for 30 min with a secondary biotinylated antibody diluted 
in IHC buffer. The secondary antibody for PR, ER and COX-II was anti-mouse IgG (Ba-
2000, Vector Laboratories, Burlingame, CA 94010 USA) diluted in IHC buffer (1:200). 
After draining, the samples were washed with IHC buffer and incubated at room 
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temperature for 30 min with streptavidin-peroxidase complex (ABC-system, Vector 
Laboratories, Burlingame, CA 94010 USA) diluted in IHC buffer according to the 
manufacturer´s instructions. After draining and washing in IHC buffer for 10 min, the 
sections were incubated with the substrate (Nova RED, Vector Laboratories, Burlingame, 
CA 94010 USA) diluted in distilled water according to the manufacturer´s instructions for 
an appropriate time for each receptor (COX-II and ER 10 min; PR 4 min). Thereafter, the 
sections were drained and washed under running tap water for 10 min. They were then 
counter-stained with haematoxylin and dried with a graded alcohol series (rapidly in 80%, 
2 x 2 min changes in 96% and 99%) and xylol (2 x 10 min). Finally they were mounted in 
Histokit (Assistant, D-37520 Osteorode, Germany) and covered with a coverslip. 
 
4.7. Semi-quantitative immunohistochemical evaluation 
 
In Experiment IV, the staining intensity for all receptors and enzymes was evaluated semi-
quantitatively from individual sections by the same person using a light microscope. For 
COX-II the cytoplasmic staining intensity was scored as no stain (0), weak (1), 
intermediate (2) or strong (3) stain. Surface epithelium, gland tubules (superficial and 
deep), gland openings and stroma (superficial or intermediate) were each evaluated 
separately. The amount of staining for ER and PR was evaluated in terms of 
immunoreactivity according to Boos et al. (1996).  Nuclear staining was classified in 
random locations in at least 500 surface epithelium, endometrial gland, gland opening and 
stromal cells. If there were insufficient numbers of target cells, all possible cells were 
counted (in one sample the minimum number of gland opening cells was 40 and 66 for ER 
and PR, respectively). 
 
4.8. Quantitative real-time polymerase chain reaction 
 
In Experiment IV, relative mRNA concentrations for endometrial receptors ERα, PR, OR 
and enzymes 20α-HSD and COX-II, and for the house-keeping gene GAPDH, were 
analyzed using quantitative real-time RT-PCR (QPCR) from the endometrial biopsy 
samples stored at -80 °C. Two deep-frozen biopsy samples were homogenized with an 
ultra turrax (Ultra Turrax T8, IKA Werke GmBH&Co KG, Germany). For total RNA 
extraction, TRIzol® Reagent (Molecular Research Center Inc. Cat. No. 15596-026) was 
used according to the manufacturer’s instructions. The resulting RNA concentration was 
52 
 
determined with spectrophotometry in a Nano Drop ND-1000 (NanoDrop Technologies, 
Wilmington, DE), and samples were diluted in RNAase-free water to a concentration of 
100 ng/μl. DNAase treatment (Sigma-Aldrich, St Louis, MO, USA, Cat. No. AMPD1) was 
applied to eliminate genomic DNA according to the manufacturer´s instructions. cDNA 
was prepared using a reverse transcription kit (Sensiscript® Reverse Transcriptase kit, 
Qiagen) in a total volume of 60 μl, according to the manufacturer´s instructions. All 
samples were run in duplicate. Programmable Peltier thermal cyclers (PTC-100®, MJ 
Research Inc., and DNA Engine, Biorad) were used for all incubations. Random primers 
(3 l, Promega, Madison, WI, USA) were first mixed with 900 ng of RNA and incubated 
at +70 °C for 10 min, after which they were cooled for 5 min. Subsequently, 45 l of RT-
PCR-mix, containing Sensiscript RT buffer, dNTPs (5 mM), RNAasin (40 IU/l, Promega, 
Madison, WI, USA) and RNAase-free water, were added and samples were incubated at 
+37 °C for 2 min. Finally, 3 l of the reverse transcriptase were added to treatment 
samples (RT+), and RNAase-free water was added to control samples (RT-) in place of 
reverse transcriptase. Incubation was continued at +37 °C for 1.5 h, and the reaction was 
stopped by heating to +94 °C for 5 min. The resulting cDNA was stored at -20 °C until 
analysis. 
 
The Applied Biosystems Assays-by-design service was used to order all-in-one-tube 
TaqMan reagent-based assays for gene expression studies (forward and reverse primers 
and probes as listed in Table 4.8.A.). All QPCR analyses were run using the ABI PRISM® 
7000 sequence detection system (Applied Biosystems, Foster City, CA, USA). For QPCR, 
5 µl of diluted cDNA sample (100 ng/µl) was used in a 20 µl reaction mixture containing 
10 µl TagMan Universal PCR Master Mix (Applied Biosystems), 1 µl 20X Assay Mix 
(Applied Biosystems) and 4 µl RNAase-free water. All the RT+ samples were run in 
triplicate for each gene and RT- samples once per gene. Two-fold serial dilution series 
were created from Day 17 endometrial cDNA samples in order to run standard curves for 
all genes. Three replicates for each ten dilution points were run in QPCR to create standard 
curves. Amplification conditions were the same for all targets assayed: one cycle at +50 °C 
for 2 min and one cycle at +95 °C for 10 min followed by 40 cycles at +95 °C for 15 s and 
at +60 °C for 1 min. Cycle threshold (CT) results in triplicate were screened for possible 
outliers (SD < 0.5), which were removed prior to further analysis (two in 20α-HSD, and 
six in COX-II), after which those samples were analyzed in duplicate only. Relative gene  
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Table 4.8.A. Forward and reverse primers and probes for genes of cyclo-oxygenase (COX-II), 
house-keeping gene GAPDH (GAPDH), estrogen receptor α (ERα), progesterone receptor (PR), 
20α-hydroxysteroid-dehydrogenase (20α-HSD) and oxytocin receptor (OR) in Experiment IV. 
 
Gene Forward primer Reverse primer Probe 
    
COX-II CGAGGACCAGCTTTCACTA
AGG 
GCAGCTTATGCTGTCTCTCTAAA
GA 
AAGTCCACCCCATGGTTC 
GAPDH CCTCAACGACCACTTTGTCA
AG 
CTGTTGCTGTAGCCGAATTCATT
G 
TCGTACCAGGAAATGAG 
ERα GGAGAAGAGTTTGTGTGCC
TCAA 
AGAGTGCTGGACAGAAATGTGT 
 
ACACTCCAGAATTAAGCAAGA
TG 
PR CCTGTGGAAGCTGTAAGGT
CTT 
CAATCGTTTCTTCCAGCACATAA
GT 
ATGCTGTCCTTCCATTGCC 
20α-HSD GACTACCTGGACCTCTACCT
CATC 
 
TGCCGTCCTCATCCAATGG 
 
AAGTCCTTCCCAGGCTTG 
OR CGTGCAGATGTGGAGTGTCT CCAGGAGCATGGCGATGAT CAAGGAAGCCTCACCTTT 
 
 
expression (RGE) was calculated using the comparative CT method (ΔΔCT method) and 
reported as n-fold differences in comparison with the sample of the lowest amount of the 
respective gene transcripts (calibrator) after normalizing the samples referring to the 
house-keeping gene GAPDH. 
 
4.9. Statistical analysis 
 
The data were analyzed using different versions of SPSS software for Windows. 
Differences in LH (Experiments I and II), E2 (Experiment IV) and P4 (all experiments) 
concentrations between different groups were analyzed using repeated measures analysis 
of variance (ANOVA) with group as the between-subject factor and time as the within-
subject factor. The significances of time effects and time by group interaction effects were 
evaluated using Greenhouse-Geisser-adjusted P-values. The differences between groups in 
incidences of short cycles were evaluated with Fisher’s exact test in all experiments. Also 
the differences between groups in incidences of anovulations after GnRH administration 
(Experiment III) were evaluated with Fisher´s exact test. The differences in the average 
diameter of the dominant follicle before ovulation between groups were analyzed using the 
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independent samples´ t-test in all experiments. Differences in time from GnRH 
administration to ovulation (Experiment II), in the size of the CL after ovulation 
(Experiment I), in the postovulatory, basal LH secretion (Experiment I) and in AUC 
(Experiments I and II) and LH peak values (Experiment I) were all analyzed with the 
independent samples t-test. In Experiment IV, the IHC results were analyzed using a 
Mann-Whitney U-test, and values for relative gene expression (RGE) from QPCR between 
groups were analyzed with one-way ANOVA. Due to the right-skewed distribution, these 
data were transformed logarithmically prior to statistical evaluation, and presented as 
geometric mean x deviation factor 
±1
. In all experiments results were expressed as means 
or percentages (± SD). The differences were considered significant at P < 0.05. 
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5. RESULTS 
 
5.1. Excluded cases 
 
Over all experiments, only those cases in which ovulation occurred less than 48 h after 
GnRH, i.e. in a clear response to GnRH administration, were included in the analysis of 
data. Most excluded cases occurred in Experiment III, when GnRH was given to heifers 
and cows either 0 or 24 h after PG, and were due to ovulatory failure. In Experiment IIIb 
in cows, after simultaneous PG and GnRH administration, 8/26 cases (4/18 treated on Day 
8, 3/5 on Day 9, and 1/3 on Day 10) were excluded. The average size of the dominant 
follicle at the time of treatment was 16.5 ± 2.2 mm and no further examinations or 
samplings were done in these cases. In Experiment IIIa, 12 heifers were excluded: ten 
belonged to Group T0, and two to Group T24. Thus significantly more cases failed to 
respond to GnRH in Group T0 in comparison with Group T24 (P < 0.01). In four of these 
excluded 12 cases the dominant follicle failed to ovulate as a response to GnRH, but 
continued to grow and ovulated 3 to 4 d after GnRH was given. At the time of GnRH 
treatment, the average size of these dominant follicles was 12.3 ± 2.3 mm (min. 11.0 mm, 
max. 15.0 mm). On ovulation day, the average size of the preovulatory follicles was 15.5 ± 
2.4 mm. The additional eight cases led to atresia of the dominant follicle and to the 
emergence of a new dominant follicle and ovulation. At the time of GnRH treatment, the 
average size of these dominant follicles was 11.9 ± 1.5 mm (min. 10.0 mm, max. 14.5 
mm). Ovulation of a new follicle occurred in three cases 5 to 6 d, and in one case 6 to 7 d, 
after GnRH administration. In four cases, the actual ovulation date remained 
undetermined. Two additional cases of heifers were also excluded due to incomplete luteal 
regression after administration of PG. In one of these cases, ovulation occurred as a 
response to GnRH, and an accessory CL developed. 
 
Sporadic exclusions occurred also in other studies. In Experiment I, a short cycle in Group 
D7 was excluded from the exact calculation of the estrus cycle length and preovulatory 
follicle size due to an anovulatory estrus and cyst formation at the end of the experimental 
period. The length of estrous cycle in this case was approximately 9 d, based on the day of 
the luteal regression. In Group D14, the data from one animal were excluded due to 
anovulation after GnRH was given. In Group C, one animal was excluded from 
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preovulatory LH analysis due to secretion starting before the sampling period. Also all 
data from one animal were excluded due to the absence of an ovulatory LH release during 
the sampling period. 
 
In Experiment II, one heifer was excluded from the analysis of LH results due to its 
biphasic LH release after 0.5 mg of gonadorelin was given: LH release started 30 min 
before GnRH administration, reached its peak value 30 min after GnRH administration, 
reverted to basal values, and rose again, reaching a new peak at 210 min after GnRH 
administration. This may have been due to spontaneous LH release at the time of GnRH 
administration. 
 
In Experiment IV, one case was excluded due to incomplete luteal regression following 
administration of PG, and the accurate cycle length could not be determined in two cases 
because luteal regression was followed by an anovulatory estrus (a normal length cycle) or 
a follicular cyst formation (a short cycle). These two cases were not included in the cycle 
length calculations. 
 
In conclusion, ovulatory failure was the major cause of exclusions, and occurred mainly 
when PG and GnRH were given simultaneously to cyclic, diestrous heifers or cows in 
Experiment III. 
 
5.2. Lengths of the estrous cycles 
 
The duration of estrous cycles was calculated from the day of induced ovulation (= Day 0) 
to the day of subsequent spontaneous ovulation monitored using daily ultrasound scanning 
in all experiments except IIIb. In Experiment IIIb, ultrasound examinations were 
performed daily from the day of simultaneous PG and GnRH treatment until the 
appearance of a new CL, thus confirming luteal regression, ovulation and the development 
of a new CL, and during the period of possible luteal regression of a short cycle. 
Thereafter, normal length cycles were followed up with daily milk samples for 
progesterone analysis until the next estrus occurred. 
 
As the length of estrous cycles in all experiments was clearly bipartite, all cases were 
further classified into either short (SC) or normal (NC) cycle length groups. The mean 
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length (± SD) and minimum and maximum values of normal length cycles and short 
estrous cycles in all experiments are presented in Tables 5.2.A. and 5.2.B., respectively. 
The incidences of induced short cycles in different subgroups and their 95% confidence 
intervals (CI), as well as numbers of cases in short and normal cycle groups are presented 
in Table 5.2.C. In Experiment I, no short cycles occurred in the control group C, i.e. the 
length of all estrous cycles exceeded 16 days. 
 
In Experiment I, the difference with regard to incidences of short estrous cycles between 
Groups D7 and D14 was not statistically significant. Also in Experiment II, the incidence 
of short cycles after either 0.1 mg (Group T100) or 0.5 mg (Group T500) of gonadorelin 
was similar. In Experiment IIIa, the incidence of short estrous cycles in Group T24 (PG 
and GnRH 24 h apart) was 47.1%, and in Group T0 (PG and GnRH simultaneously) 100%, 
the difference being statistically significant (P < 0.01). 
 
In conclusion, the length of estrous cycles in all experiments was bipartite, i.e. short or 
normal. The difference in incidences of short estrous cycles was significantly different 
when PG and GnRH were given simultaneously on Day 7 after ovulation to cyclic, diestrus 
heifers in Experiment IIIa. 
 
 
Table 5.2.A. Normal length estrous cycle, their mean length (± SD), and minimum (Min) and 
maximum (Max) values in days (d) in Experiments I to IV. 
 
Experiment Mean (d) SD (d) Min (d) Max (d) 
     
I heifers 18.8 1.0 18 20 
II heifers 19.2 2.2 17 23 
IIIa heifers 18.1 1.7 16 21 
IIIb cows 23.0 1.0 22 24 
IV cows 20.3 1.5 18 21 
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Table 5.2.B. Induced short estrous cycles and their mean length (± SD), and minimum (Min) and 
maximum (Max) value in days (d) in Experiments I to IV. D7 and D14: prostaglandin and 
gonadotropin releasing hormone given 24 h apart beginning on Day 7 or Day 14 after ovulation, 
respectively. 
 
Experiment Mean (d) SD (d) Min (d) Max (d) 
     
I heifers D7 
I heifers D14 
8.0 
7.0 
1.0 
0 
7 
7 
9 
9 
II heifers 7.9 1.1 6 11 
IIIa heifers 7.5 0.5 7 8 
IIIb cows 9.0 1.3 7 12 
IV cows 8.7 0.6 8 10 
 
 
5.3. Gonadotropin releasing hormone -induced ovulations and ovulatory follicles 
 
The mean size of the dominant follicle (± SD, mm) at GnRH administration and at 
ovulation in all experiments is presented in Tables 5.3.A. and 5.3.B., respectively. In all 
included cases of heifers that were given PG and GnRH 24 h apart starting on Day 7 after 
ovulation, the average size of the preovulatory follicle at ovulation day was 14.1 ± 1.8 mm. 
Ovulations occurred in most heifers in 24 to 30 h after GnRH was given, and in most cows 
in 24 to 36 h (Experiment IV) or in 24 to 48 h (Experiment IIIb) after GnRH 
administration. In Experiment I, one animal in Group D7 ovulated later (32 to 43 h after 
GnRH administration), and one animal in Group D14 earlier (20 to 23 h after GnRH 
administration) than the others. In Experiment II, three follicles were ovulated some hours 
earlier (24 to 26 h after GnRH given, Group T500) or later (29 to 30 h, Group T500 and 30 
to 40 h, Group T100) than other follicles. In Experiment IIIa, two follicles in Group T0 
were ovulated later than others, i.e. 30 to 47 h after GnRH administration, and in 
Experiment IV, only one cow ovulated later than 36 h after GnRH administration (between 
36 and 48 h). In Group C all ovulations occurred 60 to 84 h after CIDR removal and 22.0 ± 
3.0 to 26.5 ± 3.0 h after the maximal LH value (Experiment I). No differences between 
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Groups T100 and T500 were detected in terms of time intervals between GnRH 
administration and ovulation (Experiment II). 
 
In conclusion, the size of the preovulatory follicle is not related to the occurrence of short 
or normal length estrous cycles in cyclic dairy cows and heifers induced to ovulate with 
PG and GnRH either 0 h or 24 h apart. When estrus and ovulation are induced with PG and 
GnRH given 24 h apart during early (Group D7) or late (Group D14) diestrus, the mean 
preovulatory follicle diameter during all three days before ovulation is significantly 
different (P < 0.05). This difference in the preovulatory follicle size also occurred between 
the re-divided Groups SC and NC three days (P < 0.05) and one day (P = 0.01) prior to 
ovulation. 
 
 
Table 5.2.C. The incidence of induced short cycles (SC, %) and number of short cycles (SC/all 
cases) in different subgroups in Experiments I to IV, and their 95% confidence intervals (CI). D7 
and D14: prostaglandin (PG) and gonadotropin releasing hormone (GnRH) given 24 h apart 
beginning on Day 7 or Day 14 after ovulation, respectively. T100 and T500: PG and 0.1 mg or 0.5 
mg of gonadorelin given 24 h apart, respectively. T0 and T24: PG and GnRH given 0 or 24 h apart, 
respectively. D8, D9 and D10: PG and GnRH given simultaneously on Day 8, Day 9 or Day 10 
after ovulation, respectively. 
 
Experiment Total incidence of SC 
(%) 
95% CI Incidence of SC (%) in 
subgroups (SC/all cases) 
I heifers 67 40 – 93 D7: 100 (6/6) 
D14: 33 (2/6) 
II heifers 76 59 – 93 T100: 70 (7/10) 
T500: 80 (12/15) 
IIIa heifers 68 51 – 85 T0: 100 (11/11) 
T24: 47 (8/17) 
IIIb cows 78 73 – 83 D8: 71 (10/14) 
D9: 100 (2/2) 
D10: 100 (2/2) 
IV cows 62 35 – 88 8/13 
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Table 5.3.A. The mean size of the dominant follicle (± SD, mm) at gonadotropin releasing 
hormone (GnRH) administration in different groups (D7 and D14, T100 and T500, T0 and T24, or 
SC and NC) in Experiments I to IV. D7 and D14: prostaglandin (PG) and GnRH given 24 h apart 
beginning on Day 7 or Day 14 after ovulation, respectively. T100 and T500: PG and 0.1 mg or 0.5 
mg of gonadorelin given 24 h apart, respectively. T0 and T24: PG and GnRH given 0 or 24 h apart, 
respectively. SC and NC: short and normal length estrous cycle, respectively. 
 
 
Experiment I 
heifers 
 
Experiment II 
heifers 
 
Experiment 
IIIa heifers 
Experiment IV 
cows 
       
D7 15.2 ± 1.9 T100 13.8 ± 2.0 T0 13.6 ± 1.9  
D14 12.1 ± 0.9 T500 15.0 ± 2.1 T24 13.8 ± 2.2  
SC 14.3 ± 2.2  14.9 ± 2.1  13.4 ± 2.1 16.4 ± 2.4 
NC 11.7 ± 0.8  14.3 ± 2.0  14.4 ± 2.3 17.5 ± 4.9 
 
 
Table 5.3.B. The mean size of the ovulatory follicle (± SD, mm) at ovulation day in different 
groups (D7, D14 and C, T100 and T500, T0 and T24, or SC and NC) in Experiments I to IV. D7 
and D14: prostaglandin (PG) and gonadotropin releasing hormone (GnRH) given 24 h apart 
beginning on Day 7 or Day 14 after ovulation, respectively. C: control group. T100 and T500: PG 
and 0.1 mg or 0.5 mg of gonadorelin given 24 h apart, respectively. T0 and T24: PG and GnRH 
given 0 or 24 h apart, respectively. SC and NC: short and normal length estrous cycle, respectively. 
 
 Experiment I 
heifers 
 
Experiment 
II heifers 
 
Experiment 
IIIa heifers 
 
Experiment 
IV cows 
        
D7 14.8 ± 1.4 T100 14.0 ± 1.5 T0 13.6 ± 2.3   
D14 11.9 ± 0.5 T500 14.9 ± 1.8 T24 13.3 ± 1.9   
C 14.0 ± 2.3       
SC 14.1 ± 1.7 SC 14.7 ± 1.0 SC 13.9 ± 2.0 SC 17.6 ± 2.5 
NC 11.7 ± 0.6 NC 14.5 ± 1.0 NC 13.6 ± 1.0 NC 18.9 ± 2.5 
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5.4. LH concentration in the peripheral blood 
 
5.4.1. Preovulatory secretion of LH 
 
Secretion of LH during 6 h following administration of GnRH, representing the LH surge, 
in Experiment I (Groups D7 and D14, and SC and NC), is presented in Fig. 5.4.1.A. The 
mean LH surge in the control group (C) is presented in the same figure, and thus adjusted 
to begin when LH exceeded 3 ng/ml and to end when LH fell below 3 ng/ml. The 
preovulatory basal LH value in Group C ranged between 1.6 and 1.8 ng/ml and an increase 
above that, i.e. the LH surge, began 36.0 to 53.5 h after the CIDR removal, and lasted for 
7.5 to 10.5 h. After LH exceeded 3 ng/ml, it took 2.0 to 3.5 h to reach the maximal LH 
value in Group C. 
 
The secretion of LH did not differ between early (Group D7) and late (Group D14) 
diestrus groups, or between short (SC) and normal (NC) cycle length groups. The mean 
peak LH concentration was reached either 1.5 h (Group D7) or 2.0 h (Group D14) after 
administration of GnRH (12.2 ng/ml and 9.8 ng/ml, respectively). In Group C the mean 
peak LH concentration was 10.7 ng/ml, and similar to Groups D7 and D14. In Groups D7 
and D14, LH secretion was below 2 ng/ml 4.5 h after GnRH administration and until the 
end of sampling. 
 
The total LH secretion during 6 h after GnRH administration in Groups D7 and D14, and 
during the first 6 h of the LH surge in Group C, was evaluated in terms of AUC (± SD), 
and was 1779 ± 660, 1674 ± 316 and 2834 ± 994 ng*min/ml in Groups D7, D14 and C, 
respectively. The AUC did not differ between Groups D7 and D14 or between Groups SC 
and NC, but there was a statistically significant difference between Groups D14 and C (P < 
0.01). A similar difference, approaching statistical significance, was apparent between 
Groups D7 and C (P = 0.06). Also in Experiment II, total LH secretion was evaluated in 
terms of average AUC (± SD) during 6 h after either 0.1 or 0.5 mg of gonadorelin, and was 
903 ± 140 and 845 ± 132 ng*min/ml, respectively. This difference between groups was not 
significant. In re-divided groups SC and NC the average AUC (± SD) was 833 ± 139 
ng*min/ml and 966 ± 55 ng*min/ml, and did not differ between groups (Experiment II). 
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Fig. 5.4.1.A. LH secretion (ng/ml) in Experiment I during 6 h following the administration of 
GnRH, when PG and GnRH were given 24 h apart beginning on Day 7 (D7, n = 6) or on Day 14 
(D14, n = 5) as well as in heifers showing a short (SC, n = 8) or normal (NC, n = 3) estrous cycle 
after the treatment. In the control group (C, n = 5), LH secretion was monitored as a spontaneous 
release after CIDR removal and it was adjusted chronologically to correspond with the secretion in 
other groups. 
 
In Experiment II, when 0.1 mg or 0.5 mg of gonadorelin was given 24 h after PG, no 
significant differences were detected between the Groups T100 and T500 in the levels of 
LH curves. Average LH profiles from 1 h before to 6 h after administering 0.1 mg or 0.5 
mg of gonadorelin, i.e. in Groups T100 (n = 5) and T500 (n = 4), are presented in Fig. 
5.4.1.B. The individual LH curve rose more slowly in Group T500 than in Group T100: 
LH concentration was significantly lower (P < 0.05) in Group T500 than in T100 30 min 
and 60 min after GnRH administration. In addition to this, the peak values, 4.5 ± 0.8 ng/ml 
(T100) and 3.8 ± 1.9 ng/ml (T500), were reached somewhat later in Group T500 than in 
Group T100 (group averages 112 and 96 min, respectively). Of the nine heifers that were 
studied successfully for the LH response, 3/5 in Group T100 and 3/4 in Group T500 had a 
short estrous cycle. No significant differences between SC (n = 6) and NC (n = 3) were 
detected either in levels or profiles of LH curves. 
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Fig. 5.4.1.B. LH concentration (mean ± SD, ng/ml) during a 7 -h period beginning 1 h before the 
GnRH administration in Groups T100 (n = 5) and T500 (n = 4) (upper panel) when either 0.1 mg 
(Group T100) or 0.5 mg (Group T500) of gonadorelin was administered 24 h after PG given on 
Day 7 after ovulation. The lower panel shows the LH concentration curves (mean ± SD, ng/ml) in 
re-divided groups of short estrous cycles (SC, n = 6) and normal length cycles (NC, n = 3). * P < 
0.05. 
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In conclusion, when estrus and ovulation are induced with PG and GnRH given 24 apart to 
diestrus heifers starting on Day 7, the preovulatory secretion of LH preceding short and 
normal length estrous cycles is similar. The preovulatory LH secretion is also similar when 
estrus and ovulation are induced with PG and GnRH given 24 h apart during early (Day 7) 
and late (Day 14) diestrus. Increasing the dose of GnRH (0.1 mg vs. 0.5 mg of 
gonadorelin) had no significant effect on the preovulatory LH secretion when PG and 
GnRH were given 24 apart. Only the individual LH curve rose more slowly in Group T500 
than in Group T100: LH concentration was significantly lower (P < 0.05) in Group T500 
than in T100 30 min and 60 min after GnRH administration, and the peak values were 
reached somewhat later in Group T500 than in Group T100. 
 
5.4.2. Basal secretion of LH 
 
LH secretion parameters (mean number of pulses, mean inter-pulse interval, mean pulse 
duration, and mean basal secretion) during the 3 h sampling period on Days 1, 3 and 5 
after ovulation in all animals (Groups D7, D14 and C), and in short and normal cycle 
length groups are presented in Table 5.4.2.A. (Experiment I). Between Groups SC and NC 
no difference in basal LH secretion occurred on Days 1, 3 and 5. 
 
In conclusion, when estrus and ovulation are induced with PG and GnRH given 24 h apart 
to diestrous heifers, basal secretion of LH on Days 1, 3 and 5 after ovulation is similar 
between short and normal length estrous cycles. 
 
5.5. Peripheral blood progesterone concentration 
 
5.5.1. Progesterone concentration at PG administration and subsequent daily rise 
 
Progesterone concentration shortly before PG administration on Day 7, i.e. during early 
diestrus, was 13.4 ± 5.3 nmol/l (Experiment I, Group D7), 15.3 ± 4.8 nmol/l (Experiment 
II, Group T100), 14.5 ± 2.7 nmol/l (Experiment II, Group T500), 13.9 ± 3.9 nmol/l (T0, 
Experiment IIIa) and 13.9 ± 3.5 nmol/l (Group T24, Experiment IIIa). In cows just prior to 
a simultaneous treatment with PG and GnRH either on Day 8, 9 or 10 after ovulation, milk 
P4 concentration varied between 15.9 and 46.3 nmol/l, being on average 30.3 ± 8.9 nmol/l 
(Experiment IIIb). During late diestrus, i.e. on Day 14, P4 concentration just before PG 
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administration was 24.4 ± 6.0 nmol/l (Experiment I). Just before the CIDR removal, the P4 
concentration in the control group C was 7.6 ± 1.9 nmol/l (Experiment I). At PG 
administration the concentration of P4 was similar in Groups SC and NC (Experiment IIIa, 
IV). 
 
In Experiments I and IIIa, P4 concentration in all groups decreased to 1 nmol/l or less in 48 
h after the administration of PG or CIDR removal (Group C, Experiment I). In Experiment 
IV, the lowest mean P4 value (2.1 ± 1.3 nmol/l in Group SC and 0.4 ± 0.3 nmol/l in Group 
NC) was reached 48 h after PG administration. In Experiment IIIb with cows, milk P4 
concentration in all animals declined below 9 nmol/l in 48 h after PG treatment, but some 
exceptions occurred. In Experiment IIIa, in one heifer P4 was still 2.8 nmol/l 48 h after PG, 
and in Experiment II, the P4 concentration declined to below 1.0 nmol/l in 72 h after PG 
treatment in all heifers except two. In those two cases the lowest concentration (1.1 and 2.4 
nmol/l) was reached on Day 3 after PG administration. 
 
 
Table 5.4.2.A. Mean luteinizing hormone (LH) secretion parameters (number of LH pulses in 3 h, 
inter-pulse interval in minutes, basal LH secretion in ng/ml ± SD) during the 3 h sampling period 
on Days 1, 3 and 5 after ovulation (Day 0) in all (Groups D7, D14 and C) animals (ALL, n = 18) 
and in short (SC, n = 8) and normal (NC, n = 4) cycle length groups. 
 
LH parameter  Day 1 Day 3 Day 5 
     
Number of LH 
pulses in 3 h 
ALL 1.4 1.4 1.8 
 SC 1.5 2.0 2.5 
 NC 1.9 1.5 1.8 
Inter-pulse interval 
(min) 
 47 42 53 
Basal LH secretion 
(ng/ml) ± SD 
ALL 1.4 ± 0.4 1.4 ± 0.9 1.1 ± 0.7 
 SC 1.1 ± 0.2 1.4 ± 1.2 0.8 ± 0.7 
 NC 1.4 ± 0.2 0.9 ± 0.5 0.8 ± 0.4 
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In Experiment I in Groups SC and NC, the average blood P4 rise between Days 3 and 7 
after PG administration was 1.3 and 1.5 nmol/l/d, respectively. In Group C, P4 rose until 
blood sampling was discontinued, i.e. Day 15 after treatment, and the average rise during 
that time was 1.4 nmol/l/d (Exp. I). In Experiment II, the average rise of P4 between Days 
1 to 4 was 2.4 and 2.0 nmol/l/d in Groups T100 and T500, respectively. In Experiment IV, 
the average rise between the lowest and highest P4 value was 0.5 ng/ml/d in Group SC and 
0.4 ng/ml/d in Group NC.  
 
In conclusion, when estrus and ovulation are induced with PG and GnRH 24 h apart during 
early diestrus in cyclic heifers and cows, P4 concentration before PG is similar between 
short and normal estrous cycles. 
 
5.5.2. Maximum progesterone concentration during short and normal length cycles 
 
In the groups of short cycles in Experiment IIIa, T0s and T24s, the maximum 
concentration of P4 was reached similarly on Days 4.7 ± 0.7 and 4.6 ± 0.5 after ovulation, 
respectively (Experiment IIIa). Also in Experiment II, subgroups of short cycles, T100/SC 
and T500/SC, reached the highest P4 concentration similarly, i.e. on Day 4.9 ± 1.1 and Day 
4.8 ± 0.8 after ovulation, respectively. Individual cows exhibiting a short cycle in 
Experiment IIIb reached the maximum P4 concentration on either Day 4 (n = 1), Day 5 (n 
= 9), Day 6 (n = 2) or Day 7 (n = 2) after ovulation. In Experiment IV with cows 
exhibiting short cycles, the peak value of P4 was detected on Day 7 after ovulation. In 
Experiment I heifers exhibiting short cycles, the mean peak value of P4 was 6 days after 
GnRH administration. 
 
5.5.3. Difference in progesterone secretion during short and normal length estrous cycles 
 
In Experiments I and IV differences in the levels and profiles of P4 concentration between 
groups were analyzed from the ovulation day for 8 days. In Experiment II, differences in 
the levels and profiles of P4 concentration between groups were analyzed from the day of 
ovulation for 5 days. In Experiment IIIb, differences in P4 concentrations between groups 
were analyzed from Day 1 to Day 7 (Experiment IIIa) or Day 8 (Experiment IIIb) after 
ovulation. Between Groups SC and NC, a significant difference occurred in the level (P < 
0.05) and in the profile (P < 0.001) of P4 secretion in Experiment I (Figure 5.5.3.A). The 
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difference in the secretion profile emerged on Day 6 (P < 0.05) after ovulation and also 
occurred on Days 7 and 8 (P < 0.001). Due to variation in the occurrence of short and 
normal cycles between the groups, a corresponding significant difference in P4 secretion 
was detected between Groups D7 and D14 (P < 0.05) and between Groups D7+D14 and C 
(P < 0.01). 
 
In Experiment II, examination of the P4 profiles in subgroups SC and NC of both Groups 
T100 and T500 (Figures 5.5.3.C and 5.5.3.B, respectively) revealed no differences. In 
Experiment IIIb, a significant difference in the profiles of P4 curves emerged between 
groups SC and NC (P < 0.05), as Group SC attained the maximum P4 concentration on 
Day 5 after ovulation, whereas in Group NC the concentration rose steadily. In Experiment 
IIIb, a significant difference in the profiles of P4 curves existed between the groups SC and 
NC (P < 0.05). In group SC, the maximum P4 concentration was reached on Day 5 after 
ovulation while in group NC the concentration increased steadily. A similar significant 
difference (P < 0.001) in the secretion profile of P4 concentration during Days 1 to 7 after 
ovulation between Groups SC and NC occurred in Experiment IV. This profile difference 
emerged on Day 7 (P < 0.01) and occurred also on Day 8 (P < 0.001). The level of P4 
secretion during that time period did not differ between Groups SC and NC. 
 
 
Figure 5.5.3.A. Progesterone profiles (mean ± SD, nmol/l) during the first 12 to 15 days of the 
estrous cycle in the short (SC) and normal cycle (NC) groups after PG (=Day 0) and GnRH 
administration 24 h apart, and in the control group (C) after CIDR removal (=Day 0) in Experiment 
I. 
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Figure 5.5.3.B. Individual progesterone profiles (nmol/l) from dexcloprostenol (PG) administration 
to the second estrus in Group T500, when 0.5 mg of gonadorelin was administered 24 h after the 
PG administered on Day 7 after ovulation. 
 
 
 
Figure 5.5.3.C. Individual progesterone profiles (nmol/l) from dexcloprostenol (PG) 
administration to the second estrus in Group T100, when 0.1 mg of gonadorelin was 
administered 24 h after the PG administered on Day 7 after ovulation. 
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In Experiment IIIa, a significant difference in levels (P < 0.01) and profiles (P < 0.01) of 
P4 secretion between the groups was detected, and individual P4 profiles showed a clear 
bipartite reaction in Group T24. As a result, the cases in Group T24 were re-divided for 
further analysis based on the length of the estrous cycle into groups of short (Group T24s) 
or normal (Group T24n) length cycle. Among Groups T0, T24s, and T24n, a significant 
difference in the levels (P < 0.001) and profiles (P < 0.001) of P4 curves was detected 
(Figure 5.5.3.D). This difference appeared on Days 6 and 7, when the P4 concentration in 
Group T24n was significantly higher. No difference between Groups T0 and T24s was 
observed. 
 
The geometric mean of peripheral blood P4 concentrations and their scatter ranges in 
Groups SC and NC in Experiment IV are presented in Figure 5.6.A. 
 
 
 
Figure 5.5.3.D. Progesterone concentrations (ng/ml, mean ± SD) in Groups T0 (PG and GnRH 
administrated simultaneously), T24s (PG and GnRH administered 24 h apart, animals with a short 
estrous cycle), and T24n (PG and GnRH administered 24 h apart, animals with a normal estrous 
cycle) during the subsequent estrous cycle. PG was given in Group T0 on Day -1 and in Groups 
T24 on Day -2. Among Groups T0, T24s, and T24n, a significant difference in the levels (P < 
0.001) and profiles (P < 0.001) of P4 curves was detected on Days 6 and 7, when the P4 
concentration in Group T24n was significantly higher. No difference between Groups T0 and T24s 
was observed. 
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Figure 5.6.A. Geometric mean of peripheral blood estrogen-17β (E2, pg/mL) and progesterone 
concentration (P4, ng/mL) and their scatter ranges (Xg x deviation factor
±1
) in induced short (SC, 
n=8) and normal (NC, n=5) length cycle groups after ovulation (=Day 0) in Experiment IV. 
 
 
In conclusion, when estrus and ovulation are induced with PG and GnRH 24 apart in 
diestrus cows and heifers, a significant difference in P4 profile between groups occurs 
during the first week after ovulation. This difference is due to occurrence of induced short 
estrous cycles. 
 
5.6. Peripheral blood estradiol concentration 
 
The geometric mean of peripheral blood estradiol-17β (E2) and progesterone 
concentrations and their scatter ranges in Groups SC and NC in Experiment IV are 
presented in Figure 5.6.A. The mean peak of E2 was reached one day before ovulation, and 
was similar in short and normal cycle length groups. Thereafter in the normal cycle length 
group, the average E2 fluctuated below 4 pg/ml, except on Day 5 (5.6 x 1.8
±1
 pg/ml) and 
on days after Day 20. A peak (8.2 x 1.8
±1
 pg/ml) was reached on Day 20. In the short cycle 
length group, average E2 after ovulation was below 4 pg/ml until Day 6 and beyond. 
Differences in E2 concentration between Groups SC and NC were analyzed from two days 
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before ovulation until eight days after it. The secretion profile of blood E2 was 
significantly different between Groups SC and NC (P < 0.001). This difference emerged 
on Day 7 (P < 0.05). Also on Day 5 there was a tendency towards significance (P =0.059). 
The blood E2 concentration 24 to 48 h before ovulation did not correlate with the size of 
the ovulatory follicle. 
 
In conclusion, when estrus and ovulation are induced with PG and GnRH 24 h apart during 
early diestrus in dairy cows, the mean peak of E2 is reached one day before ovulation, and 
is similar in induced short and normal cycle length groups. Blood E2 concentration 24 to 48 
h before ovulation does not correlate with the size of the preovulatory follicle. E2 
concentration is significantly different between short and normal length estrous cycles on 
Day 7 after ovulation. 
 
5.7. Immunohistochemistry 
 
Immunostaining for ER and PR is presented in Table 5.7.A. In Experiment IV, most 
immunostaining for COX-II was noted in the cytoplasm of surface epithelial, gland tubule 
and superficial stromal cells, and no staining was evident in deep gland tubule cells. 
 
The range for COX-II immunostaining was from 0 (superficial gland tubule cells in Group 
NC on Days 2 and 5) to 1.5 ± 1.3 in gland opening cells on Day 5 in Group SC. For 
receptors ER and PR most immunostaining was noted in the nucleus of surface epithelial, 
gland tubule and gland opening cells. Significant non-specific staining was not observed. 
No statistically significant differences in any of the cell types mentioned above were 
detected in the average endometrial ER, PR or COX-II staining intensity between Groups 
SC and NC.  
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5.8. Endometrial receptor and enzyme expression 
 
In Experiment IV, for two samples taken on Day 2 after ovulation from two animals (one 
in both short cycle and normal cycle length groups), no amplicon was evident in QPCR 
and those samples were thus excluded from further analysis. Geometric means of relative 
gene expression (RGE) for ERα, OR, PR, 20α-HSD and COX-II on Days 2 and 5 in short 
and normal cycle length groups are presented in Fig. 5.8.A. No statistically significant 
difference was detected in RGE between these groups. 
 
 
Table 5.7.A. Immunoreactivity scores of endometrial surface epithelium, gland opening, gland 
tubule and stromal cells for estrogen (ER) and progesterone (PR) receptors  in animals with short 
or normal length cycles (SC and NC, respectively) on Days 2 and 5 after ovulation (=Day 0) 
calculated according to Boos et al. (1996). No significant differences between Groups SC and NC 
were evident. 
 
 
 
 
Surface 
epithelium 
Gland opening Gland tubules Stroma 
     
ER      
Day 2 SC 92 ± 108 127 ± 76 108 ± 29 64 ± 25 
 
NC 241 ± 88 163 ± 0 127 ± 30 44 ± 25 
Day 5 SC 99 ± 57 66 ± 52 97 ± 44 28 ± 14 
 
NC 129 ± 128 172 ± 0 125 ± 101 61 ± 57 
PR 
     Day 2 SC 156 ± 98 128 ± 43 132 ± 26 75 ± 29 
 
NC 153 ± 88 97 ± 0 132 ± 42 54 ± 30 
Day 5 SC 124 ± 50 122 ± 22 134 ± 23 58 ± 22 
 
NC 156 ± 19 160 ± 39 111 ± 50 69 ± 14 
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Fig. 5.8.A. Geometric mean of relative gene expression (RGE) for 20α-hydroxysteroid-
dehydrogenase (20α-HSD), cyclo-oxygenase II (COX-II), estrogen  receptor α (ERα), oxytocin 
receptor (OR) and progesterone receptor (PR) and their scatter range (Xg x deviation factor
±1
) in 
normal (white bars) and short (grey bars) cycle groups on Days 2 and 5 after ovulation (= Day 0) in 
Experiment IV. No statistically significant differences were evident among the groups (P > 0.05).   
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6. DISCUSSION 
 
6.1. Exclusion of cases 
 
In this thesis most excluded cases occurred due to ovulatory failure when PG and GnRH 
were given simultaneously to diestrous heifers or cows in Experiment III. Similarly 
disrupted follicular dynamics, premature ovulation and delayed return to normal estrus and 
ovulation were reported when Stevens et al. (1993) gave simultaneously PG and 0.1 mg of 
gonadorelin or saline to diestrous cows either on Day 8 or Day 10 after standing estrus. 
Significantly more saline-treated cows (14/16) exhibited a normal estrus within two to five 
days after treatment, in comparison with simultaneous treatment with cloprostenol and 
gonadorelin (6/16). Those treated with simultaneous cloprostenol and gonadorelin and not 
showing a normal estrus within 2 to 5 days, were further analyzed. Five cows exhibited no 
signs of estrus, ovulated within 48 h and developed an ultrasonographically detectable 
structure resembling CL, and returned to estrus 7 to 13 days later. Three showed signs of 
estrus but returned to estrus 6 to 11 days later, suggesting induced follicular atresia and 
development of a new dominant follicle, and two showed estrus on Day 4 after treatment, 
but did not ovulate. In contrast to other experiments reported in this thesis, in Experiment 
III PG and GnRH were given simultaneously, i.e. GnRH was given during high blood P4 
concentration. According to Giordano et al. (2012), the ovulatory response after 0.1 mg or 
0.2 mg of gonadorelin given to diestrous animals either during high (over 3 ng/ml) or low 
(in average 0.2 ng/ml) blood P4 concentration remained unaffected, even though the 
preovulatory release of LH was less during high blood P4 concentration in comparison with 
low blood P4 concentration. In Experiment III of this thesis, LH release after simultaneous 
treatment with PG and GnRH was not analyzed. 
 
6.2. Length of estrous cycles and incidence of induced short estrous cycles 
 
The length of estrous cycles following PG and GnRH given 0 or 24 h apart to diestrous 
dairy cows or heifers in this thesis was clearly bipartite due to occurrence of induced short 
estrous cycles in addition to normal length cycles. The maximum length of these short 
estrous cycles, 11 d in heifers and 12 d in cows, i.e. less than two weeks, and the minimum 
length of 6 d in heifers and 8 d in cows are in accordance with similar reports by Taponen 
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et al. (2002, 2003). In those studies, the approximated length of induced short cycles 
ranged between 8 to 10 d in cows (Taponen et al. 2002) and 8 to 12 d in heifers (Taponen 
et al. 2003). 
 
Simultaneous treatment with PG and GnRH on Day 7 after ovulation caused the highest 
incidence of induced short estrus cycles (100%) in cyclic, diestrous dairy heifers. This was 
also significantly more in comparison with the incidence of short estrous cycles when PG 
and GnRH were given 24 h apart. Also Bridges et al. (2010) in their two experiments 
noted that decreasing the time interval between administration of PG and 0.1 mg of 
gonadorelin from 2.2 d to 1.2 d increased the incidence of short estrous cycles in cyclic 
beef cows. When the time interval was decreased from 2.25 d to 1.25 d, the proportion of 
short cycles was significantly increased (Bridges et al. 2010). Similarly when Schmitt et al. 
(1996) gave PG and 8 μg of buserelin 24 h apart, the incidence of induced short estrous 
cycles in cyclic cows and heifers was about 35%. This incidence was an estimate, as the 
occurrences of luteal regression and ovulation were not confirmed, and the inter-
insemination interval was based on estrus detection. Similarly, Taponen et al. (2002, 2003) 
gave PG and 0.1 mg of gonadorelin 24 h apart to cyclic dairy heifers and cows. The 
incidence of short cycles was about 33% in cows (Taponen et al. 2002) and about 58% in 
heifers (Taponen et al. 2003). In those studies, the 95% confidence interval of incidences 
was wide due to small sample sizes: in cows 6% to 60%, and in heifers 30% to 86%. In 
studies included in this thesis, numbers of cows and heifers were somewhat higher and the 
total incidence of induced short estrous cycles was thus less variable than in earlier studies 
of Taponen et al. (2002, 2003). 
 
6.3. Size of the ovulatory follicle 
 
In the basic experimental setting of the work comprising this thesis, estrus in heifers was 
induced with PG during early diestrus, on Day 7 after ovulation, and 0.1 mg of 
gonadorelin for ovulation induction was given 24 h later.  No difference in the size of the 
preovulatory follicle was recorded between induced short and normal length cycles. 
Similarly, no difference in the size of the preovulatory follicle between physiological short 
estrous cycles and norgestomet-treated controls was evident in a study with beef cows 
(Shrick et al. 1993). When PG and GnRH were given during early diestrus, the 
preovulatory follicle present in the ovary was the first wave dominant follicle, which in 
76 
 
two-wave cycles in heifers reached its maximum size on Day 6 (Savio et al. 1988). The 
maximal diameter of the ovulating follicle was influenced by the stage of the cycle at the 
initiation of the GPG estrus synchronization protocol (Vasconcelos et al. 1999). During 
our experiments, the average size of the preovulatory follicle at ovulation day (14.1 ± 1.8 
mm) in all included cases of heifers that were given PG and GnRH 24 h apart starting on 
Day 7 after ovulation, was slightly larger than the mean size of the second or third wave 
preovulatory follicle in heifers (13.0 ± 0.3 mm) according to Wolfenson et al. (2004). 
When heifers in our experiments were treated with PG during late diestrus, on Day 14 after 
ovulation, and given GnRH 24 h later, the size of the preovulatory follicle was even 
smaller, 11.9 ± 0.5 mm. This size difference of the preovulatory follicles in animals treated 
with PG and followed by GnRH 24 h later either on Day 7 or on Day 14 after ovulation 
was statistically significant. 
 
A possible explanation for changes in follicle size during the estrous cycle in this study is 
that the size of the ovulating follicle is linked to hormonal changes around estrus. During 
early diestrus (Day 7) the average blood P4 concentration was significantly lower in 
comparison with late diestrus (Day 14). Vasconcelos et al. (1999) reported a connection 
between follicle size and P4 concentration in dairy cows. The lowered P4 concentration 
during the luteal phase in dairy cows is linked to the increased size of the first wave 
dominant follicle (Lüttgenau et al. 2011), reported earlier in dairy heifers by Adams et al. 
(1992) and in beef cows by Pfeifer et al. (2009). In contrast, Giordano et al. (2012) gave 
0.1 mg of gonadorelin to cows either during low or high P4 (approximately 0.2 ng/ml and 
over 3 ng/ml, respectively). As a result, the average size of the dominant follicle in both 
groups was quite similar, 17.7 mm (14 to 21 mm) and 16.9 mm (14 to 24 mm), 
respectively, but this was not statistically evaluated. 
 
In cyclic beef cows, the length of proestrus was altered when PG was given twice at a 12 h 
interval and followed by 0.1 mg of gonadorelin either 60 h or 36 h later during early 
diestrus (Bridges et al. 2012). This caused a significant decrease in the preovulatory peak 
concentration of estradiol-17β but the size of the ovulatory follicle at GnRH administration 
remained unaffected (approximately 12 mm). In contrast, follicular aspiration and 
induction of luteal regression with PG, followed by 0.1 mg of gonadorelin given when the 
dominant follicle reached 10 mm, significantly decreased the size of the preovulatory 
follicle (about -1.3 mm), shortened the proestrus (-1.5 days), and ovulation occurred about 
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1.1 d earlier than the spontaneous ovulation (Mussard et al. 2007). After induced 
ovulation, the mid-luteal P4 concentration and the conception rate were both less in 
comparison with spontaneous ovulation. Mussard et al. (2007) concluded that follicular 
maturation is probably affected by the interaction of several factors, not directly connected 
to the size of the ovulating follicle, and thus follicles need to be physiologically mature 
prior to induction of ovulation in order to avoid decreased fertility. 
 
Lüttgenau et al. (2011) assumed that the above-mentioned connection between blood P4 
concentration and follicle size during diestrus, noticed also in our experiment, was caused 
by an increase in LH pulse frequency during Days 9 to 15 after ovulation, but LH 
concentrations were not analyzed in their study. In our study, basal secretion of LH on 
Days 1, 3 and 5 after ovulation was similar between short and normal length estrous 
cycles. Reduced LH release on those days coincided with higher progesterone 
concentration. This combination of low basal LH and high P4 concentration (or the high 
basal LH and low P4 concentration) has been analyzed also in other studies: a significant 
increase in basal and mean LH concentrations occurred in animals with lowered P4 during 
the growth of the dominant follicle (Pfeifer et al. 2009). The decreased or increased P4 
concentration is respectively known to increase or decrease the LH pulse frequency 
(Bergfeldt et al. 1996). In conclusion, the decreased size of the dominant follicle was 
caused by a P4-induced decrease in LH concentration (Ginther et al. 2001a, 2001b), and 
LH and P4 oscillations were positively and temporally related (Hannan et al. 2010). On the 
other hand, ovulation of a larger follicle has been reported to create a larger CL, leading to 
increased P4 secretion (Pfeifer et al. 2009). This increase in luteal size and P4 concentration 
was, however, not reported in the study of Lüttgenau et al. (2011). 
 
6.4. Secretion of the preovulatory LH 
 
In the experiments reported here, a five-fold increase in the dose of gonadorelin (0.1 mg 
vs. 0.5 mg) given 24 h after PG to cyclic dairy heifers did not have a significant effect on 
the preovulatory release of LH. In heifers on Day 15 after previous ovulation, i.e. around 
luteal regression, the amount of GnRH needed to induce a natural-like LH peak 1 to 2 h 
after treatment was as low as 5 µg of gonadorelin (Ginther and Beg 2012). The effect of 
varying doses of GnRH on LH response has been investigated in several studies with 
inconsistent results (see section 2. Review of literature), and the variance between LH peak 
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values in different studies has been wide even when comparable GnRH doses and/or 
products have been used. This variability is probably explained by differences in 
experimental settings and analysis methods, and makes comparison among studies 
difficult. Differences in experimental settings can be responsible for conflicting results in 
the preovulatory release of LH because the quantity of LH released appears to be 
significantly affected by the endogenous milieu of steroid hormones, i.e. the stage of the 
estrous cycle (Kaltenbach et al. 1974, Mikél Jensen et al. 1983). When diestrous cows 
during high P4 (exceeding 3 ng/ml) were treated with 0.1 mg or 0.2 mg of gonadorelin, the 
preovulatory release of LH, measured as AUC, was significantly decreased in comparison 
with the same treatment given during low P4 (in average 0.2 ng/ml; Giordano et al. 2012). 
The LH peak value after administration of 0.1 mg or 0.2 mg of gonadorelin during high 
and low P4 was significantly different (3.3 ± 0.3 ng/ml and 15.7 ± 2.2 ng/ml or 8.5 ± 1.7 
ng/ml and 23.6 ± 1.6 ng/ml, respectively), but the ovulatory response after both doses was 
similar irrespective of the P4 concentration. The preovulatory release of LH exceeded 10 
ng/ml more often during low P4 (86%) in comparison with high P4 (13%), and the time to 
LH peak tended to be reached more slowly during high P4 when 0.1 mg of gonadorelin was 
used (1.3 ± 0.2 h) in comparison with other groups (approximately 0.8 or 0.9 ± 0.1 h), 
(Giordano et al. 2012). In a similar study by Giordano et al. (2013), 0.1 mg or 0.2 mg of 
gonadorelin was again given to diestrous cows. As a result, the LH response was dose-
dependent only when a functional CL was present in the ovary. Similarly in beef heifers 
more LH was released in response to 0.1 mg or 0.2 mg of gonadorelin in animals with low 
(3 ng/ml) in comparison to high (7 ng/ml) P4 concentration; pre-treatment with 0.25 mg of 
estradiol benzoate 8 h earlier did not increase the ovulatory response (Dias et al. 2010). 
Similarly to the studies above, Colazo et al. (2010) used 0.1 mg of gonadorelin in beef 
heifers and cows with low (3.0 ± 0.4 ng/ml) and high (5.7 ± 0.4 ng/ml) P4 concentration, 
and reported a smaller and shorter release of LH and fewer ovulations in animals with high 
P4 concentration in comparison with low P4. 
 
Apart from our studies, very few results on the preovulatory LH secretion preceding short 
estrous cycles have been published. In a study of Bridges et al. (2010), mean LH secretion, 
AUC and LH peak concentration after PG and 0.1 mg of gonadorelin administration either 
2.25 d or 1.25 d (54 h vs. 30 h) apart were similar for induced short and normal length 
cycles. 
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6.5. Basal secretion of LH 
 
The results for basal LH secretion reported in this thesis are in accordance with those 
reported by Swanson and Hafs (1971), Zolman et al. (1974), Schallenberger et al. (1984), 
Peters et al. (1994) and Cupp et al. (1995). The basal LH secretion values during the 
estrous cycle vary among studies, possibly due to differences in experimental settings, LH 
analysis methods and/or LH pulsatility detection methods. A more detailed discussion of 
different studies is included in section 2, the review of the literature. 
 
6.6. Blood estradiol concentration 
 
When estrus and ovulation were induced with PG and GnRH 24 h apart in cyclic dairy 
heifers, no difference in the level of blood estradiol-17β (E2) concentration during 48 h 
before ovulation between subsequent induced short and normal length cycles was detected. 
The size of the preovulatory follicle was unrelated to the E2 concentration during that time. 
In contrast, in postpartum beef cows exhibiting physiological short estrous cycles, the E2 
secretion at estrus was reported to be significantly less than in P4-treated controls (Garcia-
Winder et al. 1986, Garverick et al. 1988). The secretion of E2 during the three days before 
first postpartum estrus was significantly more preceding normal length cycles than short 
cycles (Schrick et al. 1993). Also the E2 concentration in the follicular fluid of postpartum 
beef cows was four times less if anticipated to exhibit a short cycle than in animals having 
a normal length cycle (Braden et al. 1989). The low preovulatory level of E2 and impaired 
OR inhibition were postulated to be behind postpartum short estrous cycles (Mann and 
Lamming 2000). In the absence of P4, endometrial OR levels could be decreased with 
exogenous E2 and the degree of OR expression was related to the amount of E2 secreted 
during estrus (Mann and Lamming 2000). 
 
In contrast to our studies, the time interval between PG and GnRH has been more than 24 
h in other studies investigating the release of E2 during the periestrous period preceding 
induced short estrous cycles. Similarly to physiological estrous cycles reported in the 
previous paragraph, in cyclic beef animals decreasing the time interval between 
administration PG and 0.1 mg of gonadorelin from 2.2 d to 1.2 d significantly decreased 
the E2 concentration around ovulation (Bridges et al. 2010). The peak concentration of E2 
during proestrus was also significantly decreased (Bridges et al. 2010). In most short cycle 
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cases (4/5), the preceding preovulatory E2 peak concentration was less than 10 pg/ml, and 
when the concentration of E2 was over 10 pg/ml, most cows (10/11) had a cycle of normal 
length. In a similar study, where PG and 0.1 mg of gonadorelin were given to cyclic beef 
heifers either 60 h or 36 h apart, the length of proestrus was decreased (Bridges et al. 
2012). The preovulatory peak concentration of E2 (8.9 ± 0.4 pg/ml vs. 6.7 ± 0.8 pg/ml, 
respectively) was again decreased (Bridges et al. 2012). In that study, despite the shortened 
proestrus, the P4 concentration between Days 2 and 15 after GnRH administration was 
similar between groups. In contrast to short cycle studies above, the size of the 
preovulatory follicle at induced luteal regression, above or below 10 mm, did not lead to 
differences in E2 secretion because preovulatory follicles were allowed to ovulate 
spontaneously (Robinson et al. 2005). Increased follicular size was associated with 
increased blood E2 concentration (Atkins et al. 2008). In beef cattle large follicles secreted 
more E2 on the day of ovulation induction with GnRH, and more P4 on Day 7 after 
ovulation (Mesquita et al. 2014). In that study, follicular growth was manipulated in 
physiological limits with sequential treatments of exogenous progesterone, estradiol 
benzoate, PG and GnRH, in order to create small and large preovulatory follicles 
(Mesquita et al. 2014). Thus, secretion of E2 can be an important determinant of follicular 
physiological maturation and initiation of estrus, but the absolute diameter of the follicle or 
the magnitude of GnRH-induced LH secretion are thought to be less important (Atkins et 
al. 2008). 
 
Effects of giving PG and estradiol benzoate 24 h apart are very different from the results 
obtained after PG and GnRH are given 24 h apart. When PG is given to cyclic heifers at 
the beginning of follicular dominance of the second follicular wave (i.e. Days 8 to 13 after 
estrus), and followed by estradiol benzoate 24 h later, the time to the preovulatory release 
of LH was significantly decreased in comparison with control animals, but no significant 
effect on size of the preovulatory follicle or on the time to ovulation was noticed (Evans et 
al. 2003). When PG was given at the emergence of the follicular wave to cyclic heifers, 
and followed by estradiol benzoate 24 h later, the size of the preovulatory follicle was 
significantly decreased (Evans et al. 2003). Also time to estrus and time to the 
preovulatory LH peak were both decreased in comparison with controls (Evans et al. 
2003). Neither of these treatment protocols above affected the size of the CL or the length 
of the following luteal phase. In conclusion, both GnRH and estradiol benzoate given 24 h 
after PG shorten the proestrus, but the effect on the following luteal phase is very different. 
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6.7. Endometrial receptors and enzymes analyzed with immunohistochemistry and real-
time quantitative reverse transcriptase-polymerase chain reaction and their association 
with induced short estrous cycles 
 
Our working hypothesis, that endometrial expressions of enzymes 20α-HSD and COX-II 
or receptors OR, ER and PR during metestrus and early diestrus differ for induced short 
and normal estrous cycles, was not supported. QPCR did not detect any significant 
difference between short and normal length cycles on Days 2 and 5 after ovulation. 
Moreover, semi-quantitative IHC did not indicate significant differences in the endometrial 
staining for ER or PR between induced short and normal cycles on those days. Boos et al. 
(1996), Dall`Aglio et al. (1999) and Robinson et al. (2001) among others reported that the 
follicular phase promotes endometrial PR and ER synthesis, and the luteal phase down-
regulates them. The exact causes of OR up-regulation are still not completely understood, 
but Robinson et al. (2001) assumed two possible causes. First, PR during luteal phase loses 
its dominance via down-regulation due to progesterone acting on its receptors (Robinson et 
al. 2001). Such inhibition of OR by progesterone, or progesterone block, was suggested by 
McCracken et al. (1984) in sheep. Secondly, but less probably according to Robinson et al. 
(2001), E2 might act via ER to up-regulate OR. A more detailed discussion on different 
studies concerning endometrial receptors and their regulation is provided in section 2, the 
review of the literature. 
 
Our hypothesis was based on earlier information about the cause of premature PGF2 
release during physiological short estrous cycles (i.e. first cycle after calving): endometrial 
PR concentration on Day 5 after ovulation in cows exhibiting a physiological short cycle 
was significantly lower and endometrial OR concentration significantly higher than in 
cows with normal length cycles (Zollers et al. 1993). According to those authors, E2 levels 
prior to ovulation determined the length of the subsequent P4 dominance, i.e. luteal phase, 
through altered degree of PR expression. At the time of luteal regression during short 
cycles, high concentrations of endometrial OR were present, and peaks of oxytocin and 
PGFM coincided, allowing the luteal regression to be initiated (Hunter 1991). At the time 
of maternal recognition of pregnancy, luteal regression needed to be prevented via release 
of foetal interferon-τ, which had a direct suppressive effect on the translation of OR and 
ER (Robinson et al. 2001). 
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In addition to such time-specific changes, ER and PR in cattle undergo spatial changes in 
the uterus, which further complicate the interpretation of study results: ER is expressed in 
all the layers of endometrium during estrus, in deep glands during the whole estrous cycle, 
and in increased amounts in the luminal epithelium during the mid-luteal phase, and PR is 
expressed mostly in the stroma, and the expression is maximal during estrus and the early 
luteal phase (Robinson et al. 2001). Okumu et al. (2010) prefer to use IHC when cell-
specific changes are analysed. Cell-specific changes cannot be detected using QPCR 
because during the process of QPCR tissue samples are homogenized. 
 
Prior to our study, to our knowledge, no PCR-studies were conducted to investigate 
endometrial receptor concentrations specifically during induced short cycles in cattle. 
When the length of proestrus was decreased (PG and 0.1 mg of GnRH given either 60 h or 
36 h apart), and in response to that, estradiol secretion of the preovulatory follicle was 
significantly reduced, the concentration of mRNA for ESR1 during late diestrus (Day 15 
after GnRH) fell, but the concentration of mRNA for OR remained unchanged (Bridges et 
al. 2012). On Day 15, the staining intensity in IHC for PR in deep glands was significantly 
more when the length of proestrus was 60 h than when 36 h. In a similar experimental 
setting as in Bridges et al. (2012), no difference in endometrial PR, OR and ERα 
expression was detected with QPCR one day before or on Day 7 after ovulation, when 10 
µg of buserelin was given to cows either 40 or 60 h after 0.15 mg of cloprostenol, or not at 
all (Bollwein et al. 2010). When buserelin was given 40 h after cloprostenol, 25% of the 
cows had no CL on Day 7 after ovulation (6 % when the time interval between treatments 
was 60 h and 12 % when no GnRH was used). Bollwein et al. (2010) concluded that 
changes in the expression of endometrial receptors are not a cause of decreased fertility 
after the above-mentioned synchronization protocol where proestrus is decreased, but 
inadequate follicular and luteal development are. In a recent study by Mesquita et al. 
(2014), follicular growth was manipulated in physiological limits with sequential 
treatments of progesterone, estradiol, PGF2α and GnRH to create small and large 
preovulatory follicles. On Day 7 after the last treatment with GnRH (= D0, used to induce 
ovulation), endometrial samples were collected at slaughter. Larger follicles had secreted 
significantly more estradiol on the day of ovulation induction with GnRH and the CL 
formed after them secreted significantly more progesterone on slaughter day. ERα on Day 
7 was up-regulated, and OR down-regulated in animals with larger preovulatory follicles, 
and estradiol on Day 0 was positively correlated with ERα on Day 7. The authors 
83 
 
concluded that the size of the preovulatory follicle, through changes in the peri-ovulatory 
secretion of estradiol and luteal phase secretion of progesterone, affects the expression of 
important endometrial genes during diestrus, and might affect fertility.  
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7. CONCLUSIONS 
 
When PG and GnRH are given 24 h apart to cyclic dairy heifers 
 short estrous cycles may occur both during early and late diestrus, i.e. Day 7 or 
Day 14 after ovulation  
 the dose of GnRH, 0.1 mg vs. 0.5 mg of gonadorelin, does not affect the 
occurrence of induced short estrous cycles 
 the induced preovulatory release of LH is similar for short and normal length 
estrous cycles, and unaffected by the dose of GnRH (0.1 or 0.5 mg of gonadorelin) 
 basal secretion of LH on Days 1, 3 and 5 after ovulation is similar for short and 
normal length estrous cycles, and lower LH release on those days coincides with 
higher progesterone concentration 
 the size of the preovulatory follicle is unrelated to the occurrence of short or 
normal length estrous cycles  
 early diestrous (Day 7 after ovulation) dominant follicles are larger than late 
diestrus dominant follicles (Day 14 after ovulation), probably due to lower 
preovulatory progesterone concentration and thus increased LH concentration 
during early diestrus in comparison with late diestrus 
 the timing of GnRH administration (0 h or 24 h after PG) significantly affects the 
ovulatory response and the incidence of short estrous cycles  
 
When PG and GnRH are given 24 h apart to cyclic dairy cows 
 the size of the preovulatory follicle is unrelated to the occurrence of short or 
normal length estrous cycles  
 the size of the preovulatory follicle is unrelated to the amount of estrogen secreted 
at estrus 
 the timing of GnRH administration (0 h vs. 24 h after PG), significantly affects the 
ovulatory response and the incidence of short estrous cycles 
 no difference in endometrial expression of receptors OR, ER and PR or enzymes 
20α-HSD and COX-II occurs between short and normal length estrous cycles on 
Days 2 and 5 after ovulation 
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In practice, decreased fertility warrants use of hormonal estrus synchronization protocols 
to control follicular waves and luteal regression to achieve acceptable pregnancy rates. 
During protocols that use sequential treatments of PG and GnRH, our results above should 
be taken into account to avoid decreased fertility due to occurrence of induced short 
estrous cycles. PG and GnRH should not be given simultaneously, and when given 24 h 
apart, many animals will exhibit a short estrous cycle. Ovulation failure is common if PG 
and GnRH are given simultaneously.  
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